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A variety of aging related diseases including Alzheimer‟s, Type II diabetes, 
Huntington‟s, Parkinson‟s, and Creutzfeldt-Jakob are characterized by the 
formation of abnormal proteinaceous deposits. These deposits, known as 
amyloid, are abnormal accumulations of misfolded proteins with a characteristic 
cross β-sheet conformation. The formation of amyloid fibers can occur through 
many pathways, of which one of the most important pathway is catalyzed by 
binding to the cell membrane. The peptide-membrane interaction can disrupt the 
integrity of the cell membrane, causing disruption of calcium homeostasis and 
eventual cell death.  
In  membrane-mediated aggregation, the protein is thought to initially bind 
with the membrane in an α-helical conformation before undergoing a 
conformational change during aggregation to a β-sheet form characterstic of the 
amyloid fiber. Therefore, it is important to determine atomic-level structures of 
these intermediates, as they can provide insights into the toxic mechanism 
exhibited by these amyloidogenic proteins and into the design of drugs that can 
suppress these intermediate helical species to stop further progression into toxic 
states.  
This dissertation reports high-resolution NMR structural studies of two 




related to Type II diabetes), in order to understand the role of α-helical 
intermediate structures in causing membrane disruption, (2) PAP248-286 (the 
corresponding amyloid fiber (SEVI) enhances the infectivity of the HIV virus), in 
order to understand the bridging interactions it exhibits between the host and 
viral cell membranes. 
Our studies on the membrane bound α-helical intermediates of rat and 
human IAPP/IAPP1-19 reveal a pH dependent membrane orientation for IAPP1-19, 
which correlates well with its ability to disrupt synthetic membrane vesicles and 
β-cells, and that the position of the disulfide bridge with respect to the 
hydrophobic interface of the N-terminal helix could be one of the factors that 
modulate the membrane disruptive behaviour of these peptides.  
Our study on membrane bound PAP248-286, reveals an unusual amount of 
structural disorder that, in combination with high positive charge at the N-
terminus could play an important role in the fusion of host and viral cell 








CHAPTER 1. AN INTRODUCTION TO THE AMYLOID PEPTIDES INVOLVED 
IN TYPE II DIABETES AND HIV 
 
1.1 WHAT ARE AMYLOIDS? 
 Amyloids are cross-beta fibril protein deposits that have been found in 
many amyloidogenic diseases such as Alzheimer‟s disease, Type II diabetes, 
Huntington‟s disease, Parkinson‟s disease and Creutzfeldt-Jakob disease [1-5]. 
A recent study by Muench et al., [6] has led to the discovery of another 
amyloidogenic peptide known as PAP248-286 that has been related to the 
transmission of human immunodeficiency virus (HIV). The amyloidogenic 
peptides and proteins associated with these deposits undergo a misfolding upon 
binding to the membrane from their native random coil monomeric conformation 
to intermediate helical species which later tranforms to the β-sheet that are 
characteristic of fibril deposits. This misfolding on the cell surface can have 
several consequences for the cell including cell membrane fusion, disruption of 
the integrity of the plasma membrane, and cytotoxicity. In all of these pathways, 
the intermediate helical species play an important role in cell toxicity, cell 
membrane fusion or transformation into β-fibril deposits as shown in Figure 1-1. 
The two systems we are interested in are : 1) Type II diabetes  and 2) HIV, 
where the amyloid peptide associated with the former is cytotoxic to the cell and 
the latter is non-toxic but associated with the fusion of host cell membrane with 





Figure 1-1. Aggregation pathway of amyloids 
1.2 TYPE II DIABETES 
 Type II diabetes aka non-insulin-dependent diabetes mellitus or adult 
onset diabetes is one of the most common disease worldwide. It is characterized 
by an increase in insulin resistance as well as the decreased production of insulin 
due to loss of β-cell mass in the human pancreas. Around 20.8 million people in 
the year 2005 were affected by this disease in United States alone of which 
around 20.6 million were of age 20 years or older [7]. Some of the complications 
that arise from type II diabetes are high blood pressure, heart disease & stroke, 
blindness and kidney diseases. Direct medical costs associated with the 
treatment of this disease in United States alone, was around $92 billion in the 
year 2002 [7]. In recent years, there has an alarming increase in the number of 




the average age of the US population, which has prompted interest in the 
mechanism involved in its development.  
 Amyloid deposits are commonly isolated in the pancreatic islets from the 
subjects both suffering with type II diabetes, and to a lesser degree, older 
subjects without type II diabetes [8-10]. Although the amyloid-like material was 
first observed in the year 1901 by the pathologist Dr. Opie in specimens of 
human pancreas [11], its contents were only solubilized and identified as islet 
amyloid polypeptide (IAPP) in the year 1987 by Westermark, P., et al [12, 13].  
 IAPP aka Amylin, is derived from an 89 amino acid residue precursor by 
sequential enzymatic cleavage in pancreatic β-cells. The N-terminal residues of 
the IAPP precursor from 1-18 resembles a signal peptide with a possible signal 
peptidase cleavage site located at Ala22 [14, 15]. This initial cleavage and 
oxidation of disulfide-bridge occurs in the lumen of the endoplasmic reticulum 
and results in the proIAPP precursor [16]. The 11 residue N-terminal flanking 
peptide and the 16 residue C-terminal flanking peptide of proIAPP are then 
cleaved at the dibasic amino acids sites (K10, R11 & K50, R51 by the enzymes 
prohormone convertase 2 and 1/3, respectively, in immature secretory granules 
[17-20]. In the next step, the C-terminus Lys-Arg residues are cleaved by 
carboxypeptidase E resulting in the exposure of Gly residue for attack by the 
enzyme peptidylglycine α-amidating monooxygenase (PAM), which cleaves 
CαH2COOH from Gly, leaving only the amine resulting in the amidation of the Tyr 
residue. The final product is 37 residues with a calculated molecular mass of 3.9 





Figure 1-2. IAPP processing scheme from its precursor protein. Please note that 
the oxidation of cysteine residues in ER lumen and the relative timing of PC2 
processing are not yet established. Targeted residues are indicated in red color. 
 
IAPP is co-secreted with insulin from the islet β-cells of the pancreas [26, 
27]. In its normal physiological role, IAPP acts in concert with insulin to control 
plasma glucose levels and independently of insulin as an appetite suppressor 
[28-30]. Since the amyloid deposits were most observed in the pancreas of ~95% 




identifying the region of IAPP involved in fibril formation. The most amyloidogenic 
fragment was found out to be from residues 20-29 of hIAPP [31-35]. A fiber 
model of hIAPP20-29 was developed with the help of six inter-carbon distance 
obtained from rotational resonance solid-state NMR spectroscopy. One face of 
the hIAPP20-29 amyloid β-sheet contains the side chains of G24, I26 and S28 and 
the other face the side chains of F23, A25, L27 and S29 [36]. The orientation of 
the beta sheet of the fibrils of hIAPP20-29 with respect to each other was found out 
to be antiparallel from Fourier transform infrared spectrum [37]. Another solid 
state 2H and 19F NMR study on the fibrils of hIAPP20-29 suggested a side-by-side 
arrangement of the sheet with the phenyl rings facing towards the inter-sheet 
space within a hydrophobic core [38]. Peptide based inhibitors were designed to 
target the 20-29 region of hIAPP in order to inhibit amyloidogenesis [39-43]. But 
later studies have shown that there are other amyloidogenic segments in hIAPP 
that can also independently form fibrils apart from the segment 20-29, one being 
located at the C-terminus from residues T30-Y37 and the other at the N-terminus 
from residues A8-S20 [44-49]. 
While the focus was on these amyliodogenic segments, an important 
breakthrough came in 1999, when Janson, J., et al showed that intermediate 
sized amyloid particles were toxic to human islets cells, whereas matured hIAPP 
containing large amyloid deposits did not cause cytotoxicity [50]. Voltage-
clamped planar bilayer experiments in the same study showed that membrane 
damage was induced by early aggregates of hIAPP rather than matured hIAPP 




molecules involved in membrane toxicity was determined to be between 25 to 
6000 IAPP molecules [50]. This membrane disruption activity by early hIAPP 
aggregates was supported by other studies on protofibrils of hIAPP which 
showed the permeabilization into synthetic vesicles by a pore-like mechanism 
[51, 52]. Extraction of the lipids from the membrane by growing amyloid deposits 
but not preformed fibrils was also observed by fluorescence confocal microscopy 
on lipid vesicles [53]. Other studies that followed supported the role of the hIAPP 
oligomers in the disruption of the cell membranes [54-56]. 
In one of the studies on the interaction of hIAPP with lipid membranes 
consisting of DOPG/DOPC, formation of preamyloid states were observed at the 
N-terminus but not with the C-terminus of the peptide [57]. This observation of N-
terminus interaction with the membrane was further supported by the studies on 
the fragments of the hIAPP where the N-terminal 1-19 fragment of hIAPP 
efficiently inserted into the phospholipid monolayers as a monomer while the 
insertion into the membrane could not be observed with the 20-29 fragment of 
hIAPP [58]. 
A weakly stable hIAPP α-helix of approximately 15-19 residues in length 
was observed, when hIAPP was added to membranes containing PS by CD and 
fluorescence studies [59]. This study established a role for the α-helical 
intermediates in hIAPP aggregation when bound to membranes. Emerging 
evidence supports this hypothesis of the role of membrane bound α-helical 
intermediates of hIAPP in aggregation and toxicity to the β cells [60, 61]. It was 




random coil to α-helical intermediate state upon binding to the vesicles and 
causes dye leakage from POPG liposomes but unlike full length hIAPP, hIAPP1-
19 do not form fibrils [62]. A similar result was later obtained by measuring the 
calcium influx into β-cells induced by hIAPP and hIAPP1-19. In the same study, 
the fibril forming hIAPP20-29 peptide did not cause any dye leakage from POPG 
liposomes. Therefore, it was concluded that membrane disruption can occur 
independently from amyloid formation in hIAPP, and the sequences responsible 
for these processess are located in two different regions on the hIAPP peptide 
[62]. 
Rat IAPP (rIAPP) which has around ~84% sequence similarity and differs 
from hIAPP by six different substitutions in its sequence as shown in Figure 1-3. 
In this context, it is significant that rats do not develop type II diabetes. While rat 
IAPP has been shown to sample transient α-helical states like hIAPP, it 
importantly does not progress to form amyloid fibrils [63-65]. 
But the structural insights into these transient α-helices which have been 
implicated in membrane disruption activity has been limited so far owing to 
problems involved in sample solubility and aggregation. To overcome these 
problems, we have employed micelles in order to trap the α-helical intermediate 
state of the peptide in a stable form. This micelle system was further optimized 
for structural studies of the truncated (1-19) and full length rat and human IAPP 
by solution NMR spectroscopy, which could provide insights into the mechanism 
involved in varying activities of membrane disruption exhibited by these peptides 





Figure 1-3. Primary amino acid sequences of human and rat amylin. Both the 
peptides have disulfide-bridge from residues Cys2-Cys7 and are amidated at the 
C-terminus. Residues in rat amylin that differs from human amylin are colored in 
red. 
 
1.3 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
 HIV infects around 0.6% of population worldwide. From its discovery in 
1981 to 2007, AIDS has killed more than 25 million people [66]. In 2008 alone, 
AIDS has claimed an estimated 1.7-2.4 million lives of which more than 280000 
were children [67]. Even though AIDS is pandemic, HIV is surprisingly weak 
pathogen in vitro with only <0.1% of the virus particles succeeding in infecting a 
host cell [68, 69]. Emerging evidences suggest that the viral attachment to the 
host cell membranes for its entry is the limiting factor in vitro [70-72]. Since 
semen is the main vector in the transmission of the HIV worldwide, a recent 
study on screening the components of the human semen resulted in a peptide 
fragment known as PAP248-286, the fibril form of which is known as SEVI (serum-
derived enhancer of viral infection), that showed a potent enhancement of the 
HIV infection over a broad range of HIV phenotypes [73-75]. PAP248-286 is a 39 
residue amino acid peptide fragment, as shown in Figure 1-4, and is part of a 
protein called prostatic acid phosphatase (PAP) found in the semen of humans. 
How PAP248-286 is cleaved from PAP, is not yet established but is thought to be 
cleaved by lysozyme. Since the structures of PAP248-286 are not known in any 
form, it is difficult to make predictions about the interactions of this peptide with 




thesis involves the structural studies of PAP248-286 in micelle environment by 
solution NMR spectroscopy, in order to understand the mechanism by which it 
promotes the bridging of viral and host cell membranes. 
 
Figure 1-4. Primary amino acid sequence of PAP248-286. 
1.4 STRUCTURAL STUDIES USING NUCLEAR MAGNETIC RESONANCE 
SPECTROSCOPY 
NMR techniques to solve 3D structures of water-soluble peptides and 
proteins are well-established. On the other hand, NMR techniques to study 
membrane-associated proteins are continued to be developed as these systems 
pose tremendous challenges to existing techniques. In this study, we used 
synthetic peptides of IAPP and SEVI for structural studies in model membranes 
using NMR spectroscopy. The intermediate helical structures of these peptides 
were stabilized in detergent micelles. Recombinant isotopically enriched peptides 
were not available for this study. SEVI has not been successfully biologically 
expressed, while the recombinant IAPP peptide is non-amidated at the C-
terminal, unlike the naturally occurring peptide. Since the peptides were not 
enriched with isotopes of 13C or 15N, 2D 1H-1H experiments were utilized to solve 
the structures of the peptides embedded in micelles. After optimization of micelle 
sample conditions, 1D 1H NMR experiments were performed to optimize the 
experimental conditions for structural studies. 2D 1H-1H TOCSY and 2D 1H-1H 





The 2D 1H-1H TOCSY (TOtal Correlation SpectroscopY) or HOHAHA 
(HOmonuclear HArtmann-HAnn) correlates the chemical shifts of all protons 
within each amino acid residue of the peptide or protein via scalar coupling [76, 
77]. Unlike in a 2D COSY experiment, the rotating-frame based TOCSY 
experiment renders in phase transfer of magnetization which result in in phase 
scalar coupled multiplets both in diagonal and cross peaks of the 2D spectrum. 
More details about the TOCSY experiment and the details of the spin dynamics 
can be found in the literature [76-78]. This experiment is equally important to that 
of 2D 1H-1H NOESY, as it helps in distinguishing the intra-residual peaks from 
the inter-residual peaks in a NOESY spectrum. 
 High resolution structures of the amyloid peptides in my thesis involves 
the utilization of the NOE derived distance restraints obtained from a 2D 1H-1H 
NOESY (Nuclear Overhauser Enhancement SpectroscopY) experiment. Nuclear 
Overhauser Effect (NOE) [79], which states the transfer of spin polarization from 
one nucleus to another by cross-relaxation or through space interaction, was 
named after the scientist Albert W. Overhauser who developed the hypothesis of 
Overhauser effect for the transfer of spin polarization from electron to nuclear 
spins by cross-relaxation  [80]. For two nuclei close in proximity in space, the 
strength of NOE depends on the distance between the two interacting nuclear 
spin in a 1/r6 manner. This distance dependence limit the observation of NOEs to 
distances less than or equal to 6 Ǻ. A two-dimensional NOESY experiment is 
therefore important, in providing all the NOEs of the peptide system, which can 




different simulated annealing softwares available. Therefore, NOEs provide 
important information about the secondary structure or the fold of a 
peptide/protein. More details about the NOESY experiment can be found in the 
literature [81].  
 While these 2D experiments are commonly used to investigate the atomic-
level structures of polypeptides without the need for isotopic enrichment, solving 
the high-resolution structures of amyloid peptides is a tedious problem. Since an 
amyloid peptide aggregates rapidly in the NMR timescale and the aggregated 
species do not tumble rapidly to contribute to the observed signal, applying 
multidimensional NMR experiments has been a major challenge. For this reason, 
solid-state NMR experiments have been utilized in solving the high-resolution 
structures of end products namely the amyloid fibers. While these structures are 
interesting, our main objective of this study was to solve the high-resolution 
structures of helical intermediates present in the misfolding pathways of IAPP 
and SEVI. To accomplish this goal, we trapped the helical intermediates in a 
micellar environment using detergents and applied solution NMR experiments as 
mentioned above. By optimizing the concentrations of the peptide and detergent 
and other conditions like pH and temperature, well behaved samples were 
obtained for both IAPP and SEVI. These samples were quite stable for NMR 
experiments and provided high-resolution spectral lines that enabled us the 
structure determination as reported in the following chapters of the thesis. 
Though we aimed at solving the structures of helical intermediates in the 




cell membrane is also important to understand the mechanism of cell toxicity in 
the case of IAPP and the mecanism of membrane fusion in the case of SEVI. 
Therefore, the structures determined from this study could be important to 
address the membrane behavior of these peptides even though detergent 
micelles may not be the best membrane mimetic. The use of micelles is even 
more important as structural studies of an amyloid peptide embedded in a lipid 
bilayer (a better model membrane than a micelle) are tedious due to the lipid-
induced aggregation of the peptide.  
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CHAPTER 2. STRUCTURES OF RAT AND HUMAN ISLET AMYLOID 
POLYPEPTIDE IAPP1-19 IN MICELLES BY NMR SPECTROSCOPY 
 




 Disruption of the cellular membrane by the amyloidogenic peptide IAPP 
(or amylin) has been implicated in β-cell death during type II diabetes. While the 
structure of the mostly inert fibrillar form of IAPP has been investigated, the 
structural details of the highly toxic prefibrillar membrane-bound states of IAPP 
have been elusive. A recent study showed that a fragment of IAPP (residues 1-
19) induces membrane disruption to a similar extent as the full-length peptide. 
However, unlike the full-length IAPP peptide, IAPP1-19 is conformationally stable 
in an α-helical conformation when bound to the membrane. In vivo and in vitro 
measurements of membrane disruption indicate the rat version of IAPP1-19, 
despite differing from hIAPP1-19 by the single substitution of Arg18 for His18, is 
significantly less toxic than hIAPP1-19, in agreement with the low toxicity of the 
full-length rat IAPP peptide. To investigate the origin of this difference at the 
atomic level, we have solved the structures of the human and rat IAPP1-19 
peptides in DPC micelles. While both rat and human IAPP1-19 fold into similar 
mostly α-helical structures in micelles, paramagnetic quenching NMR 
                                                            
1 Jiadi Xu helped with NMR experiments and data processing. Jeffrey Brender helped in writing 





experiments indicate a significant difference in the membrane orientation of 
hIAPP1-19 and rIAPP1-19. At pH 7.3, the more toxic hIAPP1-19 peptide is buried 
deeper within the micelle, while the less toxic rIAPP1-19 peptide is located at the 
surface of the micelle. Protonating H18 in hIAPP1-19 reorients the peptide to the 
surface of the micelle. This change in orientation is in agreement with the 
significantly reduced ability of hIAPP1-19 to cause membrane disruption at pH 6.0. 
This difference in peptide topology in the membrane may correspond to similar 
topology differences for the full-length human and rat IAPP peptides, with the 
toxic human IAPP peptide adopting a transmembrane orientation and the 
nontoxic rat IAPP peptide bound to the surface of the membrane. 
2.2 INTRODUCTION 
Islet amyloid polypeptide (IAPP, also known as amylin) is one of an 
increasing number of proteins in which the propensity to form a misfolded state is 
correlated with pathologies in tissue functioning. Physiologically, IAPP is one of a 
family of peptides related to calcitonin that act in the control of metabolic 
functions. Specifically, IAPP acts in concert with insulin to control plasma glucose 
levels and acts independently of insulin to slow gastric emptying and therefore 
food intake [1-3]. For reasons that are currently poorly understood, IAPP 
aggregates in the pancreatic β-cells of type II diabetics to form highly ordered 
and extremely stable long protein fibers (amyloid deposits). Similarly, other 
tissue-specific amyloid deposits have also been identified in a growing list as 
possible pathological features in other common and devastating diseases such 




of these proteins, despite the differences in amino acid sequences and in the 
structures of the monomeric protein, adopt a common cross-β-sheet structure 
consisting of parallel association of β-strands to form protofibril units and lateral 
association of protofibril units to form amyloid fibers [4]. Amyloid deposition is 
generally correlated with the severity of the disease, increasing over time as the 
disease progresses and β-cell function decreases [5]. 
Amyloidogenic proteins commonly exhibit a strong interaction with 
negatively charged membranes, forming oligomeric structures within the 
membrane that act as largely nonselective ion channels [6-9]. Atomic force 
microscopy images show pentameric structures with a small central cavity 
suggestive of a well-defined ion channel when IAPP is bound to supported lipid 
bilayers [6]. The formation of these ion channels has been proposed to disrupt 
calcium homeostasis and lead to mitochondrial oxidative stress [7]. However, 
other studies have shown direct disruption of the membrane by the uptake of lipid 
molecules during fibrillogenesis into protofibril units [10, 11]. In order to better 
understand the membrane interaction and function of IAPP, it is important to 
determine the high-resolution structure of IAPP in a membrane environment. 
However, the rapid aggregation of IAPP to form amyloid fibers has been a great 
challenge to overcome in solving the atomistic-level resolution structures of these 
peptides using NMR spectroscopy. In addition, the oligomeric species of IAPP 
that form during the aggregation process can interact with the membrane in 
different ways, further complicating structural studies of IAPP. To overcome the 




19 fragment of IAPP (the amino acid sequence is given in Figure 2-1) is a useful 
model system for the study of the IAPP-induced membrane disruption [12]. The 
full-length IAPP peptide can be divided into three regions: an N-terminal region 
from residues 1 to 19 that largely determines the membrane binding [13, 14], a 
primary amyloidogenic region from residues 20 to 29, and a C-terminal region 
from residues 30 to 37 that enhances amyloid formation [13, 15, 16]. Peptide 
array binding studies have shown that the N-terminal region of IAPP is also 
strongly involved in the self-association of the peptide. Using an array of 
decamer peptides made from hIAPP, Mazor et al. measured the binding of full-
length IAPP to truncated versions of the peptide immobilized on a cellulose 
membrane matrix [17]. The strongest peptide-peptide interactions in this study 
were found to extend from C7 to N21, which substantially overlaps with the 1-19 
region. It is noteworthy that the binding of full-length hIAPP to truncated peptides 
containing the main amyloidogenic region (residues 20-29) was significantly less. 
The preferential affinity of full-length IAPP for truncated peptides made from the 
N-terminal region over those made from the amyloidogenic region suggests self-
association in full-length IAPP may be initiated first by interactions in the 1-19 
region before any interactions within the 20-29 region can occur. This is 
significant because IAPP-induced toxicity and membrane damage can occur 
prior to amyloid formation as reported in the literature [7, 18]. The 1-19 fragment 
of IAPP may therefore serve as an excellent structural model to investigate the 
early aggregation and membrane disrupting activity of IAPP that is observed 




In an effort to determine the amino acid residues responsible for the 
toxicity of IAPP, we recently found that the N-terminal 1-19 region of human IAPP 
both disrupts POPG vesicles similarly to full-length human IAPP and also 
disrupts β-cell homeostasis like full-length human IAPP [12, 19]. Significantly, 
hIAPP1-19 exhibits greatly reduced amyloidogenicity, forming fibers only at very 
high concentrations in solution [20]. While binding to membranes accelerates 
amyloid formation for full-length hIAPP, human IAPP1-19 is conformationally 
stable when bound to POPG membranes, maintaining the same α-helical 
conformation for at least 13 days [12]. A similar effect has been noted for a 
longer fragment of the hIAPP (hIAPP1-24) that also contains part of the 
amyloidogenic region [21]. 
A comparison of amino acid sequences of IAPP of different species yields 
some interesting information in this context. Full-length rat IAPP is both nontoxic 
and nonamyloidogenic, and more significantly, rats do not develop type II 
diabetes. However, the human and rat versions differ in only one amino acid 
residue within the 1-19 sequence (Figure 2-1) with the majority of the differences 
between human and rat IAPP being in the amyloidogenic 20-29 region.   
 
Figure 2-1. Amino acid sequences of rat and human IAPP. The 1-19 region is 
shown in blue, and differences between the sequences are shown in red. A 
disulfide bond connects residues 2 and 7. The C-termini of the peptides used in 
this study are amidated like the naturally-occuring peptides. 
 
Despite the fact that it differs from human IAPP1-19 by only a single 




fragments of human and rat IAPP are quite stable in a membrane environment 
[12], it would be useful to determine the high-resolution structures and folding of 
these peptides using NMR spectroscopy. In this study, we have solved the high-
resolution structures of both human and rat IAPP1-19 peptides using solution NMR 
experiments on well-behaved dodecylphosphocholine (DPC) detergent micelles. 
In most respects, DPC micelles are a better model to mimic the phospholipid 
membrane than organic solvents, such as trifluoroethanol and hexafluoro-2-
proponal, which have been used in some previous studies of amyloid peptides 
[22]. Organic solvents lack the hydrophobic/hydrophilic interface that is present in 
lipid membranes. Furthermore, the difference in solvation structure and hydrogen 
bonding between organic solvents and lipid membranes tends to bias the 
structure toward non-native helical structures [23-25]. The headgroup of DPC is 
identical to phosphatidylcholine, the most common lipid in animal cell 
membranes, and is expected to be less denaturing than sodium dodecyl sulfate 
(SDS) due to the zwitterionic nature of the detergent. Previous studies have 
shown that DPC preserves the native conformations of membrane associated 
peptides and enzyme activity of membrane proteins in some cases [25-30]. 
2.3 MATERIALS AND METHODS 
2.3.1 NMR Sample Preparation. Rat and human IAPP1-19 were synthesized and 
purified by Genscript. The formation of an intramolecular disulfide bond was 
determined by electrospray mass spectroscopy. The absence of intermolecular 
disulfide bonds was confirmed by nonreducing SDS-PAGE electrophoresis, 




peptides were first dissolved in hexafluoro-2-propanol at a concentration of 10 
mg/mL and then lyophilized overnight at 1 mTorr vacuum to completely remove 
the solvent. The NMR sample was prepared by dissolving the lyophilized peptide 
to a final concentration of 1.625 mM in 20 mM phosphate buffer at pH ∼7.3 
containing 10% D2O, 200 mM perdeuterated DPC, and 120 mM NaCl. 
2.3.2 NMR Experiments. All NMR experiments except the paramagnetic 
quenching experiments were performed at 30°C on a Bruker Avance 900 MHz 
spectrometer equipped with a cryoprobe. Complete assignments of the side 
chain and backbone resonances were obtained using 2D 1H-1H TOCSY (with a 
70 ms mixing time) and 2D 1H-1H NOESY (with 100 and 300 ms mixing times) 
experiments with 2056 complex points in the direct dimension and 512 points in 
the indirect dimension [31, 32]. Proton chemical shifts were referenced to the 
water proton signal at the carrier frequency. All 2D spectra were processed using 
Bruker TopSpin software and analyzed using SPARKY [33, 34]. Resonance 
assignment was carried out using a standard approach reported elsewhere [35]. 
2.3.3 Structure Calculations. The rIAPP1-19 and hIAPP1-19 structural ensembles 
were calculated starting from an extended structure using the simulated 
annealing protocol available in the NIH-XPLOR software package to generate 
100 conformers. An initial temperature of 3000 K was used with 18000 high 
temperature steps, 9000 cooling steps, and a step size of 2 fs [36, 37]. A total of 
180 and 208 NOEs from rIAPP1-19 and hIAPP1-19, respectively, were classified as 
strong (1.8-2.9 Å), medium (1.8-4.5 Å), or weak (1.8-6.0 Å) and utilized as 




correlation between α proton chemical shifts and dihedral angles using the 
TALOS module in NMRPIPE [38]. Final refinement of the structure ensemble 
was calculated using simulated annealing at an initial temperature of 500 K with 
20000 cooling steps and a step size of 3 fs. 
The analysis was carried out using the “accept.inp” routine included in the 
NIH-XPLOR software package with the requirements that NOE violations should 
not exceed 0.5 Å, dihedral angle restraint violations should not exceed 5°, the 
RMS difference for bond deviations should not exceed 0.01 Å from ideality, and 
the RMS difference for angle deviations should not exceed 2° from ideality. The 
20 lowest energy conformers for each of the rat and human IAPP1-19 peptides 
were selected for further analysis. The analysis of Ramachandran angles for the 
20 lowest energy structures was carried out using PROCHECK-NMR (39). 
Peptide structures were analyzed using the program MOLMOL (40). 
2.3.4 Paramagnetic Quenching. One-dimensional 1H chemical shift spectra of 
IAPP1-19 in DPC micelles at a concentration of 0.4, 0.8, and 1.2 mM MnCl2 at pH 
7.3 and pH 6.0 were obtained. 2D 1H-1H NOESY spectra of hIAPP1-19 in DPC 
micelles at pH 6.0 with and without 1.2 mM MnCl2 were also obtained on Bruker 
Avance 600 MHz spectrometer. All other experimental conditions were the same 
as described above. 
2.4 RESULTS 
2.4.1 Assignments, Constraints and NMR Structures. A combination of 2D 
1H-1H TOCSY and 1H-1H NOESY spectra obtained at different mixing times was 




assignments were accomplished using the amide proton to α proton region of the 
2D 1H-1H NOESY spectra obtained at a 300 ms mixing time. The α-proton 
chemical shift index plots for both peptides are given in Figure 2-2. Due to 
chemical exchange, the chemical shift values for the α protons of K1-T4 and T6 
 
Figure 2-2. α-Proton chemical shift index of micelle bound rat (top) and human 
(bottom) IAPP1-19 measured from solution NMR experiments. 
 
of both peptides could not be observed. The fingerprint regions of NOESY 
spectra obtained at a 300 ms mixing time are shown in Figure 2-3. From the 
analysis of the 2D NOESY spectra, we have identified and assigned a total of 
180 (73 intraresidue and 107 interresidue) NOEs for rIAPP1-19 and 208 (79 
intraresidue and 129 interresidue) NOEs for hIAPP1-19. Figure 2-4 shows a 
summary of backbone NOEs for the secondary structure assignment with a 
histogram indicating the number of NOEs per residue. 




micelles are sufficiently resolved to assign most of the resonances but not to 
measure the J coupling constants. All assigned NOEs were then converted into 
distances and modeled using the classical simulated annealing protocol built in 
XPLOR-NIH [6]. Out of the 100 refined structures, 41 of the rat IAPP1-19 and 60 of  
 
Figure 2-3. Fingerprint regions of 2D 1H-1H NOESY spectra of rat (top) and 
human (bottom) IAPP1-19 embedded in DPC micelles at pH 7.3 showing 
sequential α proton NOE connectivities. 
 
the human IAPP1-19 did not have NOE violations >0.5 Å, dihedral angle restraint 
violations >5°, RMS difference for bond deviations from ideality >0.01 Å, and 
RMS difference for angle deviations from ideality >2°. Of the structures that 
passed the acceptance criteria, 20 structures were further selected for the final 
analysis. The superposition of backbone atoms from residues 1 to 19 gives an 
RMSD of 0.58 ± 0.12 and 0.57 ± 0.13 Å for rIAPP1-19 and hIAPP1-19 respectively, 
while the superposition of all heavy atoms gives an RMSD of 1.69 ± 0.28 and 
1.51 ± 0.27 Å. The overlays of the backbone and side chain heavy atoms for the 
final selected conformers are shown in Figure 2-5. Analysis of the 




residues fall in the most favored region while the rest of the residues fall in the 
additionally allowed regions for rIAPP1-19 and hIAPP1-19, respectively (more 
details are given in Table 2-1).The secondary structure representations of rIAPP1-
19 and hIAPP1-19 are shown in Figure 2-6. 
 
Figure 2-4. Histogram of NOEs versus residues for rat (top) and human (bottom) 
IAPP1-19. 
 
2.4.2 Paramagnetic Quenching Studies. Since rIAPP1-19 and hIAPP1-19 differ 
significantly in their functions but have similar structures, it is important to 
determine the orientation of both peptides with respect to the membrane. As a 
first approximation of the membrane orientation, we have obtained the 1D 1H 
chemical shift spectra of both peptides in DPC micelles with varying 
concentrations of the paramagnetic quencher MnCl2. It is known that manganese 
ions affect the relaxation rate of nuclei that are in close proximity and therefore 




penetrate into the interior of the micelle, the observed changes in the signal 
intensities reflect the exposure of the amino acid residues of the peptide to 
solvent. The 1D 1H chemical shift spectra of DPC micelles containing hIAPP1-19  
 
Figure 2-5. An ensemble of conformers for rat (A and C) and human (B and D) 
IAPP1-19 showing the convergence of the conformers for backbone atoms (A and 
B) and side chain atoms (C and D). 
 
and rIAPP1-19 at pH 7.3 are given in Figure 2-7. The considerable decrease in the 
signal intensities and broadening of spectral lines observed for micelles 
containing rIAPP1-19 even at the relatively low concentration of 0.4 mM MnCl2 
suggest that the peptide is well-exposed to the water phase and not in the 
hydrophobic core of the micelle. 
 
Figure 2-6. Secondary structure representations of an overlaid ensemble of 




On the other hand, a significant reduction in signal intensities and an 
increase in line broadening is observed only at a high concentration of MnCl2 (1.2 
mM) for micelles containing hIAPP1-19 at pH 7.3, which suggests that the peptide 
is inserted into the hydrophobic core of the micelle. 
 
Figure 2-7. The amide-proton chemical shift region of 1H NMR spectra of rat (left) 
and human (right) IAPP1-19 in DPC micelles at pH 7.3 with and without MnCl2. 
 
Overall, these results suggest that hIAPP1-19 is inserted into the micelle at 
pH 7.3 while rIAPP1-19 binds closer to the surface. The only difference between 
hIAPP1-19 and rIAPP1-19 is the H18R mutation. Histidine is likely to be neutral at 
pH 7.3; therefore, if the origin of this effect is the difference in charge at residue  
18, hIAPP1-19 should adopt a surface-associated binding mode at a lower pH 
where H18 is protonated. Accordingly, we have measured both the 1D 1H 
chemical shift (Figure 2-8) and 2D 1H-1H NOESY (Figure 2-9) spectra of hIAPP1-
19 in DPC micelles at pH 6.0 in the presence of MnCl2. In contrast to the modest 
decrease in signal observed at pH 7.3 when MnCl2 is added (Figure 2-7), there is 
a significant decrease in signal intensity at pH 6.0 with the addition of MnCl2 




hIAPP1-19 in DPC micelles at pH 6.0, but not at pH 7.3, indicates hIAPP1-19 is 
significantly closer to the surface of the micelle when H18 is protonated. 
 
Figure 2-8. The amide-proton chemical shift region of 1H NMR spectra of hIAPP1-
19 in DPC micelles at pH 6.0 with and without MnCl2. A comparison of these 
1H 
spectra with those given in Figure 2-7 for hIAPP1-19 in DPC micelles at pH 7.3 
suggests that the peptide is relatively more exposed to the water phase at pH 6.0 
and therefore peaks are considerably broadened even at 0.8 mM MnCl2. 
 
2.5 DISCUSSION 
Since the toxicity of amyloid peptides to cells is correlated with the role of 
amyloid peptides in aging-related diseases [9, 41, 42], there is considerable 
current interest in solving high-resolution structures of amyloid peptides in a 
membrane environment. Several studies have reported global changes in the 
secondary structures of amyloid peptides upon binding to membrane and their 
significance in the conversion of nontoxic to toxic amyloids [18, 43-45]. While the 
importance of IAPP/lipid interactions is well documented, the only available high-
resolution structure of membrane IAPP is for the 20-29 fragment in sodium 




is significantly lower than that of the full-length IAPP peptide [47]. In this study, 
we report the first atomic-level resolution structures of a membrane-bound IAPP 
peptide that exhibits significant toxicity [12, 19]. A previous NMR study has 
reported the low-resolution structure of nontoxic rat IAPP in water [48]. While this 
study was in progress, a recent study reported the structure of IAPP using 
distance constraints measured from EPR experiments on liposomes containing 
selectively spin-labeled IAPP peptides [21]. 
 
Figure 2-9. Fingerprint region of 2D 1H-1H NOESY spectra of hIAPP1-19 in DPC 
micelles at pH 6.0 in the absence (A) and presence (B) of 1.2 mM MnCl2. 
 
The structures of hIAPP1-19 and rIAPP1-19 in DPC micelles are similar, 
consisting of a single helix extending from C7 to V17 and a distorted helical turn 
from C7 to the N-terminus (Figure 2-10). The N-terminal region is prevented from 
adopting a canonical α-helix conformation by the disulfide bridge from C2 to C7. 




shown by the lack of NOE restraints in this region (Figure 2-4). This region may 
be more structured in hIAPP1-19, as HA-NH connectivity was seen from C7 to 
Q10 and A8 to Q10 for hIAPP1-19 but not in rIAPP1-19. As these residues border 
the disulfide bridge from residues 2 to 7, a change in the dynamics at one end of 
the disulfide bridge is likely to be transmitted throughout the ring from residues 2 
to 7. 
 
Figure 2-10. (A) Overlay of the average structures of rIAPP1-19 (blue) and hIAPP1-
19 (red). The average of the 20 structures of each peptide was aligned using the 
STAMP algorithm present in the Multiseq utility in VMD [54, 55]. (B) Top view of 
rIAPP1-19 and hIAPP1-19 from the N-terminus. (C) View of rIAPP1-19 showing the 
curve in the helical region. (D) View of hIAPP1-19 showing the absence of a curve 
in the helical region. 
 
This finding is supported by recent NMR data on full length rat and human 
IAPP in solution [48, 49]. While both rat and human IAPP are predominantly 
unstructured in solution, both peptides transiently sample α-helical states in 




hIAPP1-19, full-length hIAPP in solution has a greater α-helical propensity at the 
N-terminus than rIAPP [49]. Yonemoto et al. reported the presence of strong (i, i 
+1) amide-amide NOEs and negative Hα chemical shift deviations across the 
entire sequence of hIAPP, indicating all residues of hIAPP sample α-helical 
dihedral angles [49]. Analysis of temperature coefficients and chemical shift 
deviations show that the corresponding stretch of rat IAPP with a propensity to 
form α-helical states is shorter, stretching only from A5 to S19 [48]. Notably, the 
chemical shift deviations in the α-helical forming region are larger for full length 
hIAPP than rIAPP in solution [48, 49]. 
Table 2-1. Statistical information for the structural ensembles of rIAPP1-19 and 
hIAPP1-19. 
 
                                                                                                                          rIAPP1-19 hIAPP1-19 
Distance constraints             
                                            Total                                                                       
                                            Intra-residual                                                            
                                            Inter-residual                                                           
                                            Sequential (i - j = 1)                                                











Structural statistics   
                                            NOE violations (Å) 
                                            Dihedral angle restraint violations (º) 
                                            RMSD for bond deviations (Å) 
                                            RMSD for angle deviations (º) 
                                            RMSD of all backbone atoms (Å) 
                                            RMSD of all heavy atoms (Å) 
0.059 ± 0.0007 
1.034 ± 0.104 
0.005 ± 0.0001 
0.755 ± 0.009 
0.58 ± 0.12 
1.69 ± 0.28 
0.056 ± 0.0014 
1.589 ± 0.138 
0.005 ± 0.0002 
0.643 ± 0.021 
0.57 ± 0.13 
1.51 ± 0.27 
Ramachandran plot   
                                            Residues in most favored region (%) 






Although high-resolution structures of membrane-bound full-length IAPP 
are not available, both lower resolution studies on full-length IAPP in liposomes 
and in solution suggest the conformation determined here may represent the 
structured part of the full-length protein. The majority of the remaining residues 
on the C-terminal end of the full length protein are likely to be unstructured both 




labeled full-length hIAPP has indicated that residues 9-22 form a helix when 
bound to anionic liposomes, while the surrounding N-terminal and C-terminal 
regions are less ordered without a defined secondary structure [21]. In 
accordance with these data, circular dichroism has shown that approximately 
40% of full-length human IAPP and 35% of full-length rIAPP are in a helical 
conformation when bound to the membrane [18, 43]. The NMR studies 
mentioned above on full-length IAPP in solution also support the model of a C-
terminal region with weaker helix propensity than the N-terminal region [48, 49]. 
While the structures of rIAPP1-19 and hIAPP1-19 are quite similar, the H18R 
substitution has a strong effect on the orientation of the peptide with respect to 
the membrane. The difference in the location of hIAPP1-19 and rIAPP1-19 in the 
membrane can be seen in Figure 2-7. The signal for rIAPP1-19 is diminished 
substantially upon the addition of the paramagnetic quencher MnCl2 even at low 
concentrations, while the signal for hIAPP1-19 is hardly affected. Since the Mn
2+ 
ion cannot penetrate into the hydrophobic core of the micelle, the absence of 
quenching by Mn2+ for hIAPP1-19 indicates rIAPP1-19 is located closer to the 
surface of the membrane than hIAPP1-19 [50]. The structural basis for this 
difference is most likely due to the anchoring of R18 in rIAPP1-19 to the phosphate 
group of the DPC molecule by a charge-charge interaction. The anchoring of 
rIAPP1-19 to the surface of the membrane at two points by the charges on K1 and 
R18 would likely fix the position of the peptide within the micelle [51]. The effect 
of anchoring of rIAPP1-19 to the surface of the micelle can be seen in the structure 




hydrophobic residues of the amphipathic helix on the concave side and the polar 
and charged residues on the opposite side that is absent in the corresponding 
helix of the hIAPP1-19 structure (Figure 2-10C). Distorted helices usually occur 
when the peptide binds near the surface of the micelle, with the structure 
adopting some of the curvature of the micelle surface. Because hIAPP1-19 at pH 
7.3 lacks the C-terminal charge of R18 in rIAPP1-19, it possesses a greater 
degree of orientational flexibility. Without the requirement that residue 18 must be 
anchored to the surface, hIAPP1-19 can adopt an orientation that buries it deeper 
within the micelle. The importance of charge in determining the binding topology 
of hIAPP1-19 can be clearly seen by comparing the effect of MnCl2 on the proton 
spectrum of hIAPP1-19 at pH 7.3 and at pH 6.0. In contrast to the modest 
quenching observed at pH 7.3 (Figure 2-7), MnCl2 strongly quenches the signal 
at pH 6.0 (Figures 2-8 and 2-9). This is a strong indication that hIAPP1-19 adopts 
a surface-associated binding mode similar to rIAPP1-19 when H18 is protonated. 
Interestingly, neutron diffraction experiments have suggested a similar 
difference in topologies for the full-length rat and human IAPP peptides [52]. A 
surface-associated peptide is expected to strongly disorder the packing of the 
bilayer by creating a void beneath the peptide that must be filled by the acyl 
chains of nearby phospholipids; such effects have been reported for membrane-
disrupting antimicrobial peptides based on solid-state NMR studies in lipid 
bilayers [56, 57]. A transmembrane peptide, on the other hand, does not create a 
void volume in the membrane and can be expected to have little effect on the 




density profile of the bilayer measured by neutron diffraction in the presence of 
full-length hIAPP is remarkably similar to that of the bilayer in the absence of the 
peptide [52]. The density profile of bilayers containing full-length rIAPP, on the 
other hand, showed a significant reduction in density in the hydrophobic core of 
the bilayer, consistent with the splaying of acyl chains to occupy the void volume 
created with a surface-associated peptide [52]. Critically, water was detected in 
the interior of the bilayer in this experiment when human but not rat IAPP was 
added, indicating that a transmembrane orientation is related to the membrane 
disruption induced by human IAPP but not rat IAPP [52]. The importance of 
peptide binding topology for membrane disruption is in agreement with our 
results reported in the companion paper, which show that the membrane 
disruption by hIAPP1-19 is reduced at pH 6.0 and is approximately equal to that of 
rIAPP1-19 at pH 6.0 [19]. 
An alternative topology for full-length hIAPP has been proposed by 
Apostolidou et al. in studies using spin-labeled IAPP bound to anionic liposomes 
in the presence of quenchers with different lipid penetration profiles [21]. They 
found that full-length human IAPP was oriented parallel to the membrane surface 
in these conditions with the center of the helix located 6-9 Å below the phosphate 
group. In this EPR study, a very low (1:1000) peptide-to-lipid ratio was used, and 
it is therefore likely the peptide was in the monomeric state. It can clearly be seen 
from Figure 2-5 that a monomeric IAPP peptide in a transmembrane orientation 
would have unfavorable electrostatic interactions due to the presence of the 




the spherical micelle used in this study allows the charged side chain of R11 to 
easily extend outside/near the surface of the micelle regardless of the overall 
orientation of the peptide. In larger liposomes, a correct orientation of the peptide 
is necessary to stabilize this charge. In the surface-associated orientation, the 
charge on a monomeric peptide can be stabilized by interactions with either the 
headgroups or phosphates of the interfacial region [21]. In order to avoid this 
unfavorable interaction in a transmembrane orientation, oligomerization of the 
peptide is necessary. The binding of hIAPP to the membrane and the membrane 
disruption induced by hIAPP are both strongly cooperative, and saturation of 
IAPP binding occurs at a higher density than is possible with a surface 
associated orientation [18]. This suggests a model in which IAPP first binds to 
the membrane in a monomeric form, recruits other IAPP monomers to the 
surface, and then inserts into the membrane as an oligomer with a water-filled 
channel that stabilizes the unfavorable charge [18]. It should be noted that a 
transmembrane orientation would imply a hydrophobic mismatch for both hIAPP1-
19 and full-length hIAPP if the remaining residues in full-length hIAPP are 
unfolded as suggested by EPR, CD, and NMR studies on homologous peptides 
[18, 21, 43, 53]. 
2.6 CONCLUSION 
In conclusion, we have solved the high-resolution structures and found the 
membrane orientations of human and rat IAPP1-19 using NMR experiments on 
dodecylphosphocholine micelles in an effort to understand the functional 




evidence suggests this region is responsible for most of the membrane damage 
induced by hIAPP [12-14, 19]. The structure determined here may hold insights 
into both the normal physiological action of IAPP and the damage to β-cell 
membranes caused by the pathological aggregation of IAPP. Future studies are 
needed to determine the structure of the oligomeric forms of IAPP at high 
resolution and to understand the role of membrane composition in the structural 
folding of oligomeric IAPP. 
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CHAPTER 3. THREE-DIMENSIONAL STRUCTURE AND ORIENTATION OF 
RAT ISLET AMYLOID POLYPEPTIDE PROTEIN IN A MEMBRANE 
ENVIRONMENT BY SOLUTION NMR SPECTROSCOPY 
This chapter is a version of a manuscript published in J. Am. Chem. Soc. (2009) 
131, 8252-8261.2 
3.1 ABSTRACT 
Islet amyloid polypeptide (IAPP or amylin) is a 37-residue peptide hormone 
associated with glucose metabolism that is cosecreted with insulin by β-cells in 
the pancreas. Since human IAPP is a highly amyloidogenic peptide, it has been 
suggested that the formation of IAPP amyloid fibers is responsible for the death 
of β-cells during the early stages of type II diabetes. It has been hypothesized 
that transient membrane-bound α-helical structures of human IAPP are 
precursors to the formation of these amyloid deposits. On the other hand, rat 
IAPP forms transient α-helical structures but does not progress further to form 
amyloid fibrils. To understand the nature of this intermediate state and the 
difference in toxicity between the rat and human versions of IAPP, we have 
solved the high-resolution structure of rat IAPP in the membrane-mimicking 
detergent micelles composed of dodecylphosphocholine. The structure is 
characterized by a helical region spanning the residues A5 to L23 and a 
disordered C-terminus. A distortion in the helix is seen at R18 and S19 that may 
be involved in receptor binding. Paramagnetic quenching NMR experiments 
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indicate that rat IAPP is bound on the surface of the micelle, in agreement with 
other nontoxic forms of IAPP. A comparison to the detergent-bound structures of 
other IAPP variants indicates that the N-terminal region may play a crucial role in 
the self-association and toxicity of IAPP by controlling access to the putative 
dimerization interface on the hydrophobic face of the amphipathic helix. 
3.2 INTRODUCTION 
 Islet amyloid polypeptide (IAPP; also known as amylin) is the major 
component of amyloid deposits found in the pancreas of type II diabetic patients. 
Since amyloid deposits are observed in approximately 95% of diabetic patients 
but are rarely found in nondiabetic individuals, it has been hypothesized that 
IAPP fibrillization is involved in the pathogenic development of the disease.4-6 
More specifically, aggregates of IAPP have been implicated in the loss of β-cell 
mass and a reduction in insulin production [1]. Disruption of the β-cell membrane 
is central to this process [2, 3]. IAPP oligomers, but not the mature amyloid 
fibers, have been shown to induce apoptosis by the disruption of calcium 
homeostasis and the creation of oxidative stress. The mechanism of membrane 
disruption by IAPP and other amyloid proteins is still a subject of considerable 
debate [3-5]. 
A cross-species comparison of IAPP sequences has shown an interesting 
correlation between the occurrence of a type II like form of diabetes and the 
propensity of the corresponding IAPP sequence to form amyloid fibers. Humans, 




Revealingly, a type II diabetic-like syndrome has been observed in all these 
mammals. Out of the nonamyloidogenic forms of IAPP, the rat variant (rIAPP, 
sequence shown in Figure 3-1) has been the most intensively studied. In contrast 
to the human form of IAPP (hIAPP), rIAPP is almost completely nontoxic to β-
cells even at high concentrations. Significantly, rats do not develop diabetes-like 
symptoms even when rIAPP is overexpressed [6]. 
 
Figure 3-1. Amino acid sequences of rat and human IAPP with non-conserved 
residues shown in red color in the rat IAPP sequence. Both the peptides are 
amidated at the C-terminus and have a disulfide bridge from Cys2 to Cys7. 
 
The nontoxicity of rIAPP has usually been attributed to its inability to form 
the β-sheet amyloid fibers characteristic of hIAPP. However, mature amyloid 
fibers are relatively inert compared to the high toxicity exhibited by prefibrillar 
oligomeric species. Protofibrillar intermediates have been implicated in disturbing 
cellular homeostasis by disrupting the cellular membrane, either through the 
formation of ion channels or by a nonspecific general disruption of the lipid 
bilayer. The structure of the earlier intermediate species is unknown. The 
sequence of rIAPP differs from hIAPP primarily by the substitution of prolines for 
critical residues in the amyloidogenic region of hIAPP [7, 8]. Since prolines act as 
β-sheet breakers, the absence of rIAPP cytotoxicity has been interpreted as 
evidence for the theory that the highly toxic prefibrillar intermediates of IAPP 
possess a similar β-sheet-enriched structure as the mature hIAPP fiber. 
However, membrane disruption by hIAPP is a complex process with contributions 




initial increase in the permeability of the membrane occurs immediately upon the 
addition of the peptide to the membrane [9]. This is followed by a larger increase 
in permeability, corresponding to a complete disruption of the membrane that is 
correlated with the formation of amyloid fibers [4, 10-13]. The biphasic nature of 
membrane disruption is mirrored by biphasic changes in the conformation of the 
peptide. Both rIAPP and hIAPP are predominantly α-helical when initially bound 
to the membrane, as shown for rIAPP in this study and by circular dichroism (CD) 
and electron paramagnetic resonance (EPR) data for hIAPP bound to 
phospholipid vesicles [9, 14-16]. From this α-helical intermediate state, both 
rIAPP and hIAPP then aggregate to form β-sheet fibers. The initial increase in 
membrane permeability after IAPP binding may be linked to the formation of 
pores caused by the self-association of several α-helical IAPP monomers on the 
membrane [9]. 
The importance of these helical intermediate states of IAPP has been 
shown by fragments of IAPP (IAPP1-19) which form the helical intermediate state 
when bound to the membrane but do not progress from this state to form amyloid 
fibers [17-19]. The toxicity of these fragments mirrors the relative toxicity of the 
full-length versions of IAPP [17, 19]. Rat IAPP1-19 is significantly less toxic than 
hIAPP1-19, despite differing from hIAPP1-19 by only one residue (a substitution of 
arginine for histidine at residue 18). Although rIAPP1-19 is less toxic to β-cells than 
hIAPP1-19, it is still considerably more toxic than rIAPP1-37, which does not disrupt 
membranes of less than 50% anionic lipid content (the typical range for a β-cell is 




sufficient, but not necessary, for membrane disruption. 
To understand how structural differences in the initial helical state may 
affect the formation of later aggregates and the process of membrane disruption 
by IAPP, we have solved the high resolution structure of rIAPP in 
dodecylphosphocholine (DPC) micelles from two-dimensional (2D) NMR 
experiments. Previous studies have shown interesting differences between the 
transient helical conformational states in rIAPP and hIAPP; however, the 
transient nature of these states has prevented the collection of sufficient distant 
constraints to create a high resolution structure [21, 22]. The high-resolution 
structure reported here also gives insight into the interaction of IAPP with its 
membrane-bound G-coupled protein receptor. 
3.3 MATERIALS AND METHODS 
3.3.1 NMR Sample Preparation.  Rat IAPP amidated at the C-terminus was 
synthesized and purified by GenScript. The purity of the peptide was checked by 
analytical HPLC. The homogeneity and purity of the peptide sample was also 
proved by NMR experiments. The formation of the intramolecular disulfide bond 
from residues 2-7 was verified by electrospray mass spectroscopy. The 
lyophilized peptide was dissolved in hexafluoroisopropyl alcohol at a 
concentration of 10 mg/mL and then lyophilized overnight under vacuum to 
completely remove the solvent. Samples were prepared for NMR measurements 
by dissolving 3 mg of lyophilized peptide in 20 mM phosphate buffer at pH ∼ 7.3 
containing 10% D2O, 120 mM NaCl, and 200 mM perdeuterated DPC 




samples were tested for stability before and after NMR experiments using CD 
experiments at different temperatures. 
3.3.2 NMR Data Collection and Processing. All NMR spectra of IAPP 
embedded in DPC micelles were recorded at 30 °C using a Bruker spectrometer 
operating at a 1H resonance frequency of 900 MHz equipped with a triple-
resonance z-gradient cryogenic probe optimized for 1H detection. The 2D 
TOCSY (total correlation spectroscopy) spectrum of the sample was obtained for 
a 70 ms mixing time using 512 experiments in the indirect dimension, each with 
32 scans and a recycle delay of 2 s. 2D 1H-1H NOESY (nuclear Overhauser 
enhancement spectroscopy) spectra of the same sample were obtained for 100 
and 300 ms mixing times using 512 experiments in the indirect dimension, each 
with 64 scans and a recycle delay of 2 s. Complex data points were acquired for 
quadrature detection in both the frequency dimensions of these 2D experiments. 
All spectra were zero-filled in both dimensions to yield matrices of 2048 x 2048 
points. Both TOCSY and NOESY spectra were used in the complete assignment 
of backbone and side-chain resonances. Proton chemical shifts were referenced 
to the water proton signal at 4.7 ppm (at 30 °C). All 2D spectra were processed 
using NMRPIPE and TopSpin software from Bruker and analyzed using SPARKY 
[23, 24]. Resonance assignment was carried out using a standard approach 
reported elsewhere [25]. 
3.3.3 Structure Calculations. Structure calculations were performed using the 
X-PLOR-NIH program. An extended structure of rIAPP was used as a starting 




temperature of 4000 K for the generation of an initial 100 structures [26, 27]. 
Subsequently, these structures were refined using a further SA step and energy 
minimization. The final refinement was carried out using the refine_gentle.inp 
protocol, which gradually introduces the van der Waals radii. A total of 485 NOEs 
from the rat IAPP were classified into three distance categories according to their 
peak intensities obtained from SPARKY analysis-strong (1.8-2.9 Å), medium 
(1.8-4.5 Å), and weak (1.8-6.0 Å)-and used in the structure calculations of which 
262 were intra-residue and 223 inter-residue NOEs (Table 3-1). The torsion 
angle restraints were obtained from the TALOS module 
(http://spin.niddk.nih.gov/bax/software/TALOS) in NMRPIPE using the Hα 
chemical shift values [28]. The few ambiguous angles found in the loop region 
were assigned an additional 60° of conformational freedom compared to their 
predicted values. Of the 100 structures generated, the 10 lowest energy 
structures were selected for further analysis. Those structures selected had no 
violations of (a) NOE constraints higher than 0.5 Å, (b) bond angles higher than 
5°, and (c) bond lengths higher than 0.05 Å. The covalent geometry of the 
conformers generated was determined using PROCHECK_NMR [29]. 
3.3.4 Paramagnetic Quenching. One-dimensional 1H chemical shift spectra of 
rat IAPP in DPC micelles at concentrations of 0.4, 0.8, and 1.2 mM MnCl2 and at 
a pH of 7.3 were obtained. All other experimental conditions were the same as 
mentioned above. 
3.3.5 Differential Scanning Calorimetry. Multilamellar vesicle samples for 




rIAPP in methanol with DMPC/DMPG (7:3) in chloroform. Samples were then 
vortexed and dried under a stream of nitrogen gas to create a lipid-peptide film. 
Residual solvent was removed from the film by placing the samples under high 
vacuum overnight. After the drying process, sodium phosphate buffer (50 mM 
Na2PO4 with 150 mM NaCl at pH 7.3) was added to the dry lipid film, followed by 
vortexing, several freeze-thaw cycles, and brief sonication. The total molar 
concentration of lipid was kept constant (5.9 mM) for each sample while the 
molar peptide concentration was varied as indicated. A total of four heating and 
four cooling scans were run with a temperature range of 5-45 °C. The heating 
scans were run at 0.25 °C/min, whereas the cooling scans were run at 1.0 °C/min 
with a 10 min equilibration period between scans.  
Table 3-1. Statistical information for the structural ensemble of rat IAPP. 
                                                                                                                           
Distance constraints            
                                            Total                                                                       
                                            Intra-residual                                                            
                                            Inter-residual                                                           
                                            Sequential (i - j = 1)                                                






Structural statistics  
                                            NOE violations (Å) 
                                            Dihedral angle restraint violations (º) 
                                            RMSD for bond deviations (Å) 
                                            RMSD for angle deviations (º) 
                                            RMSD of all backbone atoms (Å) 
                                                         Ala 5 – Val 17 
                                                         Ala 5 – Leu 23 
                                            RMSD of all heavy atoms (Å) 
                                                         Ala 5 – Val 17 
                                                         Ala 5 – Leu 23 
 
0.0554 ± 0.0008 
1.3053 ± 0.0609 
0.0051 ± 0.0010 
0.8158 ± 0.0180 
 
0.22 ± 0.07 
0.52 ± 0.19 
 
0.72 ± 0.15 
1.24 ± 0.21 
Ramachandran plot  
                                            Residues in most favored region (%) 
                                            Residues in additionally allowed region (%) 
                                            Residues in additionally allowed region (%) 
                                            Residues in disallowed region (%) 
75.9 
20.3 
  1.4 
  2.4 
 
The data was converted to molar heat capacity using the average 




volume of 0.988 mL/g for the lipid mixture. Excess heat capacity was calculated 
by subtracting a baseline with buffer in both the reference and sample cells at the 
same scanning rate. 
3.4 RESULTS 
3.4.1 Assignments, Constraints and NMR Structures.  Micelles containing the 
detergent DPC and the rat IAPP were prepared for NMR measurements as 
mentioned in the previous section. As with all membrane-bound peptides, sample 
preparation is a key step in obtaining the high-resolution spectra of rat IAPP. In 
our analysis of different experimental conditions, we determined that rat IAPP 
behaves well with DPC, giving rise to very well-resolved and unique resonances 
for each of the amide sites in the 2D TOCSY spectrum. In an effort to optimize 
spectral resolution and sensitivity, several 1D 1H spectra were acquired over a 
temperature range of 25-45 °C. Only marginal chemical shift changes were 
observed for the N- and C-termini and the more solvent-exposed residues 
(residues 24-37), whereas the majority of the residues did not exhibit any 
chemical shift variation. This demonstrates that the structure is essentially the 
same at all the temperatures analyzed. The best compromise between resolution 
and sensitivity was found to be at 30 °C, and we have chosen this temperature to 
carry out our NMR experiments. Since IAPP peptides are known to aggregate, 
the micelles were further tested for stability using CD experiments at different 
temperatures. The CD spectra suggested that the rIAPP-DPC micelle was quite 
stable even after several months and the peptide had significant helical structure 




it was concluded that the sample was suitable for NMR measurements to 
determine the high-resolution structure and topology of the membrane-
associated peptide. 
A combination of 2D 1H-1H TOCSY and 2D 1H-1H NOESY spectra was 
used for the assignment of backbone and side-chain resonances. The 2D 1H-1H 
NOESY spectra of the rat IAPP obtained in deuterated DPC micelles at pH 7.3 
displays numerous, well-resolved cross-peaks, with more than 1.00 ppm spectral 
dispersion in the amide region indicating that the peptide is well-folded. This 
spectrum demonstrates numerous NOEs such as dNN(i, i + 1) and dαN(i, i + 3) that 
are diagnostic for α-helices as shown in Figure 3-2. The sequential assignments 
were accomplished using the amide proton to α-proton region of the 2D 1H-1H 
NOESY spectrum obtained at a 300 ms mixing time. Spectra obtained at mixing 
times of 100 and 300 ms were nearly identical, except that the longer mixing time 
produced relatively stronger cross-peaks. The α-proton chemical shift index (CSI) 
plot for the rat IAPP is given in Figure 3-3. Chemical shift values for α-protons 
were not observed for residues K1, C2, and P28, most likely due to fast 
relaxation suppressing the signal intensity for these residues. Due to high quality 
of the spectra, the assignment of resonances was straightforward, with the 
exception of residues in the flexible C-terminal region of the peptide. The 
fingerprint region of the assigned 2D NOESY spectrum of the peptide obtained at 
a 300 ms mixing time is shown in Figure 3-4. 
 We have identified and assigned a total of 485 (262 intraresidue and 223 




summary of backbone NOEs for the secondary structure assignment with a 
histogram indicating the number of NOEs per residue is given in Figure 3-5. 
 
Figure 3-2. A summary of the sequential and medium-range NOE connectivities 
for rIAPP in DPC micelles at 30 °C, pH 7.3. The intensities of the observed NOEs 
are represented by the thickness of lines and are classified as strong, medium, 
and weak, corresponding to upper bound constraints of 2.9, 4.5, and 6 Å, 
respectively. 
 
From the density of dαN(i, i + 1), dNN(i, i + 1), and dβN(i, i+ 1) NOE 
correlations, it is possible to identify three distinct regions: an N-terminal helix 
encompassing Ala5-Val17, a short helix from Ser20-Leu23, and a third, long 
flexible loop region consisting of residues 24-37. Taken together, the NOE and 
CSI data support the presence of a predominantly α-helical structure within the 
Ala5-Leu23 region, with the stretch of residues from Ala5-Val17 and Ser20-
Leu23 acting as a more stable core. 





Figure 3-3. α-Proton chemical shift index (CSI) for rat IAPP showing the 
propensity of IAPP to form an α-helix at the N-terminal region of the peptide. The 
CSI was calculated by subtracting the values measured for the peptide from the 
random coil shifts reported in the literature [25]. 
 
predominantly disordered. The RMSD analysis supports the presence of higher 
disorder at the C-terminus of the helical region. The RMSD between structures is 
0.52 ± 0.19 for the Cα backbone atoms and 1.24 ± 0.21 for all heavy atoms from 
residues 5-23. For the Cα atoms of N-terminal well-ordered region (residues 5-
17), the calculated RMSD decreases to 0.22 ± 0.07 and 0.72 ± 0.15 for the 
backbone and heavy atoms, respectively. This difference in backbone RMSD 
clearly shows that the 5-17 region of rat IAPP is relatively stable and that the 
helical region from residues 18-23 is more disordered. The overlays of the 
backbone and side-chain heavy atoms for the final selected conformers are 
shown in Figure 3-6. The secondary structure representation of rIAPP is shown 
in Figure 3-6C. 
 All the measured distances and predicted dihedral angles were 
subsequently modeled using SA calculations with the XPLORNIH program. The 




energy structures show that residues V26, L27, T30, and S34 fall in the 
disallowed region of the Ramachandran plot. This is most likely due to the high 
mobility of the C-terminal region as well as the presence of the proline residues 
(P25, P28, and P29) toward the C-terminal end of the peptide. 
 
Figure 3-4. The fingerprint region of 2D 1H-1H NOESY spectrum of rat IAPP 
showing the NOE α-proton connectivities. A single resonance was detected for 
each residue except for Val 26, which has two resonance peaks. 
 
3.4.2 Positioning of rIAPP in the Micelle. A first approximation of the 
membrane orientation of rIAPP was obtained using the paramagnetic quencher 
Mn2+ to identify those residues of the peptide that are exposed to solvent. 
Paramagnetic manganese ions decrease the signal intensity of nuclei that are in 
close proximity to the ion by increasing the relaxation rate. Because manganese 
ions cannot penetrate into the hydrophobic interior of the micelle, changes in 






Figure 3-5. A histogram of NOEs vs the residue number for rat IAPP, showing 
the number of intraresidue, sequential (i - j = 1), and mediumrange (i - j = 2, 3, 4) 
NOEs. Long-range (i - j > 4) NOEs were not observed. 
 
The 1D 1H chemical shift spectra of DPC micelles containing rIAPP and 
varying concentrations of MnCl2 (0.4, 0.8, and 1.2 mM) are given in Figure 3-7. 
The considerable shift and broadening of peaks from micelles containing rat 
IAPP at low concentrations of MnCl2 suggest that the peptide is in general well-
exposed to the water phase and not deeply buried in the hydrophobic core of the 
micelle. 
 
Figure 3-6. Ensemble of conformers for rat IAPP showing the convergence of 
conformers for backbone atoms (A) and side-chain atoms (B). (C) Secondary 
structure representation of an overlaid ensemble of conformers for rat IAPP. Two 
helices, an ordered helix (A5-V17) and a more disordered helix (S20-L23), can 




To identify the exposure of specific residues to solvent more precisely, 2D 
1H-1H TOCSY spectra were used to monitor the changes in the chemical shift 
and signal intensity of individual α-proton peaks after the addition of 0.8 mm 
MnCl2. The percentage decrease in the signal intensity of the α-proton chemical 
shift resonances calculated from the TOCSY spectra is given in Figure 3-8.  
 
 
Figure 3-7. Amide-proton chemical shift region of 1H NMR spectra of rat IAPP in 
DPC micelles at pH 7.3 with and without MnCl2. The spectral intensities were 
normalized. 
 
Exact intensity calculations could not be made for some residues, either 
due to overlapping chemical shifts (A13 with G33 and F15 with L23) or the 
absence of peaks in the 1H-1H TOCSY spectrum even without paramagnetic ions 
(K1, C2, R11, N22, G24, P25, P28, P29, and N35), and therefore the quenching 
data for these residues is not included in the plot. It is interesting to note that the 
decrease in the intensity of the α-proton chemical shift resonances upon the 





Figure 3-8. Percentage decrease in the signal intensity of α-proton chemical shift 
resonances of rat IAPP embedded in DPC micelles at pH 7.3 after the addition of 
0.8 mM MnCl2. 
 
region (A5-V17) than in the flexible but structured helix (R18-L23) and the 
unstructured C-terminus (G24-Y37), indicating that the C-terminal region is 
significantly more exposed to the solvent. Thus, the site-specific paramagnetic 
quenching results clearly indicate that the N-terminal part of rat IAPP is a stable 
helix that is bound to the surface of the membrane, whereas the C-terminal is 
mobile and is exposed to the solvent, as supported by the random coil structure 
as well as the large decrease in signal intensity of α-proton chemical shift 
resonances upon exposure to paramagnetic quencher MnCl2. 
3.4.3 Differential Scanning Calorimetry of rIAPP in Vesicles. The interaction 
of rIAPP with phospholipid membranes was also characterized by alterations of 
the main phase transition as detected by differential scanning calorimetry. The 
main phase transition is associated with the melting of the acyl chains in the 
hydrophobic core of the membrane from the rigid gel phase to the more fluid 
liquid-crystalline phase. This phase transition is sensitive to the binding of 
peptides to the membrane, in particular to the depth at which the peptide 
penetrates into the bilayer. The degree of perturbation of the phase transition is 




the peptide localizes in the bilayer at the glycerol region preceding the acyl 
chains and less for peptides that bind only at the top of the bilayer or insert into 
the membrane in a transmembrane orientation [30-32]. Rat IAPP reduces the 
phase transition temperature (melting temperature (Tm), enthalpy change (ΔH, 
equal to the area of the transition on the thermogram), and cooperativity of the 
transition (related to the width of the transition) (Figure 3-9). The transition is 
asymmetric at higher concentrations (>1.0% rIAPP), suggesting rIAPP may be  
 
Figure 3-9. Differential scanning calorimetry of the pre-transition and the main gel 
to liquid-crystalline phase transition of 7:3 DMPC:DMPG vesicles at the indicated 
molar ratio of rIAPP to lipid. Peptide and lipids were co-dissolved in a 
chloroform/ethanol solution, dried, and re-suspended in sodium phosphate 
buffer, pH 7.3 with 150 mM NaCl. 
 
forming peptide-rich domains or forming clusters of DMPG-rich domains [19]. 
The degree of reduction is significant, but less than that observed for peptides 
known to bind near the glycerol region [33-35]. Taken together with the 
paramagnetic quenching data, DSC suggests rIAPP binds at the surface of the 
membrane with the disordered loop extending into the solvent. 
3.5 DISCUSSION 
Early intermediates in the misfolding pathway have been implicated in 




type II diabetes, Alzheimer‟s disease, and Parkinson‟s disease. Since damage to 
the cellular membrane has been identified as a major source of the toxicity of 
amyloid proteins, it has been recognized that solving the atomic-level resolution 
structures of amyloid peptides and proteins in a membrane environment would 
provide insights into their toxic properties [36-41]. Such atomic-level resolution 
structural insights will enable the design of compounds to suppress the toxicity of 
amyloids and will therefore aid the design of drugs to treat amyloid diseases. 
Unfortunately, structural studies have been difficult as these systems are not 
amenable for X-ray diffraction studies due to the difficulty in obtaining high-quality 
single crystals. In this study, we have investigated the 3D structure of rIAPP in a 
detergent micelle using NMR spectroscopy in order to understand the folding of 
intermediates of IAPP in membrane and the origin of toxicity of the hIAPP 
peptide by looking at its nontoxic rIAPP counterpart which forms similar folding 
intermediates and can disrupt membranes under certain conditions [9, 11, 15]. 
The high-resolution structure of membrane-bound rIAPP determined here 
resembles the transient helical forms of both rIAPP and hIAPP in solution, with 
some differences as outlined below [21, 22]. The structure of rIAPP in DPC 
micelles is dominated by an N-terminal helical region from residues A5 to L23 
and a disordered C-terminus. In solution, the helical region of rIAPP is shorter 
than in the membrane-bound form, spanning residues 5-19, whereas residues 
20-23 are involved in hydrogen bonding interactions with the helix but do not 
adopt a helical conformation [22]. Human IAPP, which lacks the conformational 




in solution that extends throughout the entire molecule except for the N-terminal 
ring which is conformationally constrained by the disulfide bond between 
residues 2 and 7 [21]. The helical propensity for hIAPP in solution is greatest, 
however, in the N-terminal section up to residue 20 which is similar to the results 
presented here [21]. 
Some hypotheses about the driving force for membrane catalyzed 
aggregation can be directly supported by comparing the rIAPP with the very 
recently solved structure of unamidated hIAPP in SDS micelles [42]. The 
structure of hIAPP bound to SDS has an overall fold similar to that of rIAPP in 
DPC micelles, consisting of an ordered N-terminal helix, a flexible hinge region, 
and a less ordered helix that is followed by a disordered C-terminus. The N-
terminal helical region in the rIAPP structure (5-17) corresponds to a similar 
stretch of helical residues in the hIAPP structure (5-17) as well as in a lower 
resolution EPR study of spin-labeled hIAPP bound to small unilamellar vesicles 
(9-22), as can be expected by the very high degree of sequence homology in this 
region [14]. A flexible region that corresponds to the center of the loop in the β-
hairpin structure of the IAPP amyloid fiber is seen in both structures [43-45]. This 
hinge may also have implications for the binding of IAPP to its receptor as 
discussed below. The major difference between the two structures is in the C-
terminal region, which is completely disordered in the rIAPP structure but 
consists of a dynamic helix (S20-L27) followed by a disordered C-terminal tail in 
the hIAPP structure. Membrane-catalyzed aggregation is believed to proceed 




formation of β-sheet structure in the disordered regions [9, 46]. The formation of 
secondary structure in unstructured regions of the peptide upon self-association 
is believed to be a major contributor to the binding energy of hIAPP to 
membranes and is also thought to be responsible for the cooperativity seen in 
the binding of hIAPP to membranes [9]. Our structure confirms that a large 
section of the rIAPP peptide remains unstructured when bound to the membrane. 
The lesser degree of structure in the C-terminus of rIAPP is likely to impact the 
early self-association of rIAPP in several ways. First, it is probable that the 
additional helix present in the hIAPP structure provides an additional ordered 
interaction surface to nucleate self-association. Second, if the C-terminus of 
rIAPP cannot form ordered structures, as the DPC micelle bound peptide 
structure indicates, a large contribution to energy of self-association is lost. It has 
been shown that proline mutations outside the amyloidogenic region of IAPP 
(proline substitutions at positions 17, 19, and 30) result in a large inhibition of 
amyloid formation and the loss of amyloid fiber stability [47]. In light of the 
differences between rIAPP and hIAPP structures in the C-terminal region, it 
would be interesting to further investigate the effect of mutations that stabilize or 
destabilize secondary structure specifically in this region [48, 49]. 
In solution, the prolines of rIAPP are predominantly, but not exclusively, in 
the trans conformation. A small percentage of the P25 and P28 residues, but not 
P29, are in the cis conformation as shown by the observation of α-α NOE 
connectivities for P25 and P28 that are diagnostic for the cis conformation [22]. 




trans conformation than those in rIAPP in solution as multiple resonances are 
only seen for V26, and not for G24 and L27. This indicates P28 and P29 are 
exclusively in the trans conformation when bound to the membrane, and only 
P25 is undergoing slow cis/trans isomerization. The C-terminal residues of rIAPP 
from T30 are in an extended, disordered conformation extending outward from 
the helix. The disordered C-terminus does not interact with any other part of the 
rIAPP molecule, as shown by the absence of long or medium-range NOEs. Rat 
IAPP is a monomer in the micelle as shown by the absence of long-range NOEs 
for the side-chain atoms. 
Rat IAPP binds to the surface of the micelle in an orientation that has been 
associated with low cytotoxicity in other amyloid peptides. Most of the 
residues in rIAPP are highly quenched by the water-soluble Mn2+ ion. Since the 
Mn2+ ion cannot penetrate into the hydrophobic core of the micelle, this result 
indicates most of the residues in rIAPP are located at solvent-accessible sites in 
the micelle. A peptide bound to the surface of the micelle will have a periodic 
quenching efficiency reflective of the asymmetric solvent exposure of the two 
faces of the helix. On the other hand, a helix that is deeply inserted into the 
micelle will be largely insensitive to the presence of Mn2+ ions, except for 
residues at the ends of the helix that extend into the solvent or into the interfacial 
region of the micelle. In the rIAPP sample, the quenching efficiency oscillates 
periodically in the main helical region from T6 to approximately R18, with 
maximal quenching occurring approximately every i + 4 residues as is expected 




residues also indicates rIAPP is relatively tightly bound to the micelle and not 
dissociating from the surface despite the neutral overall charge on DPC. The 
unstructured C-terminus (G24-Y37) of the peptide is almost completely quenched 
by Mn2+, indicating this region extends out of the micelle into the solvent (Figure 
3-10). Although the orientation of the N-terminal region cannot be directly 
determined from the quenching data due to the lack of signal in this area, it can 
be inferred that this region curves toward the micelle based on the hydrophobicity 
of these residues. 
 
Figure 3-10. A cartoon representation of rIAPP binding to the surface of the 
micelle. The micelle structure was obtained from a molecular dynamics 
simulation of 54 DPC molecules in explicit water [78]. 
 
The importance of membrane binding topology in controlling the toxicity of 
IAPP has been illustrated by experiments on the rat and human versions of the 
IAPP1-19 fragment. Human IAPP and hIAPP1-19 have similar toxicity to β-cells 
[17]. The analogous rIAPP1-19 peptide is significantly less toxic despite differing 
from hIAPP1-19 only by the single substitution of Arg for His at residue 18 and can 
only disrupt membranes at high peptide to lipid ratios which are likely to facilitate 




the two peptides is associated with a corresponding difference in membrane 
binding topologies. At neutral pH, hIAPP1-19 is buried within the micelle, whereas 
rIAPP1-19 adopts a surface associated binding mode. Protonation of H18 in 
hIAPP1-19 moves the peptide to the surface of the micelle and is accompanied by 
a corresponding decrease in toxicity [18, 19]. Neutron diffraction, fluorescence 
anisotropy measurements, and analysis of packing density all suggest a similar, 
deeply inserted binding mode for the full-length human IAPP peptide [9, 16, 50]. 
Although EPR quenching experiments have shown a surface associated 
topology for hIAPP at low peptide-to-lipid ratios, [14] it is likely that this topology 
is associated with peptide in a monomeric form that is associated with low toxicity 
[9, 19]. 
Differences in the position and flexibility of the N-terminal loop contribute 
to differences in self-association for IAPP variants. The differences in the 
location of the peptides within the membrane observed are insufficient to explain 
the relative toxicity of IAPP variants. Although both rIAPP1-19 and full length 
rIAPP adopt a surface-associated orientation, there are still significant 
differences in toxicity between the two peptides [19]. Although the full-length 
rIAPP peptide is almost entirely nontoxic, rIAPP1-19 is moderately toxic to β-cells. 
Significantly, rIAPP1-19 can disrupt membranes at high peptide-to-lipid ratios, 
suggesting that although membrane-mediated oligomerization is impaired in 
rIAPP1-19 it is not almost entirely absent as it is in rIAPP. Membrane insertion 
cannot easily occur for IAPP without oligomerization, as the charged arginine 




without the formation of a water-filled channel or major distortions of the bilayer. 
As oligomerization is essential for cooperative membrane binding and membrane 
disruption, structural differences in rIAPP which affect self-association may 
explain the lack of toxicity of this peptide. Aggregation of the IAPP peptide is 
believed to be mediated by favorable coiled coil interactions among the leucine 
residues located on the hydrophobic face of the amphipathic helix [9]. Blockage 
of this site can therefore be expected to be associated with a decrease in self-
association and toxicity. Intriguingly, both properties correlate with the position 
and flexibility of the N-terminal loop (residues 2-7). In all the membrane-bound 
IAPP structures solved thus far, this region adopts a loosely coiled conformation 
due to the structural constraints imposed by the C2-C7 disulfide bridge. In the 
structure of the highly toxic hIAPP and hIAPP1-19 peptides, the N-terminal loop is 
bent away from the hydrophobic interface [18]. In this position the hydrophobic 
side of the helix is exposed and can mediate hydrophobic interactions that favor 
the formation of a helical bundle (Figure 3-11, parts A and B, respectively). 
Conversely, in the structure of nontoxic rIAPP this loop is bent toward the 
hydrophobic face of the helix in a manner that would block binding of IAPP to the 
hydrophobic face of the helix (see Figure 3-11C). The N-terminus of moderately 
toxic rIAPP1-19 is also tilted toward the hydrophobic face of the helical region 
(Figure 3-11D) [18]. However, the N-terminal loop of rIAPP1-19 is considerably 
more flexible than that of rIAPP. The extra flexibility in the N-terminus of rIAPP1-19 
is likely to facilitate a movement of this region away from the hydrophobic face of 




be seen by a comparison of the NOEs in this region. The N-terminal loops of 
both 1-19 fragments are only constrained in by HA-NH connectivity in the 
residues adjoining the disulfide bridge and not by any constraints within the N-
terminal loop itself, indicating a significant degree of flexibility within the N-
terminal loop. The full-length rIAPP structure, on the other hand, has several 
NOEs within the disulfide bridge, indicating a considerably more rigid N-terminus. 
 
Figure 3-11. Structures of hIAPP1-19 (A), hIAPP (B), rIAPP (C), and rIAPP1-19 (D) 
showing the degree of occlusion of the putative self-association site by the N-
terminal loop in each structure. The hydrophobic residues that have been 
implicated in coiled-coil interactions stabilizing the IAPP oligomer are colored in 
blue. 
 




to residue 18, and it may seem paradoxical that the N-terminal regions are 
different in the absence of any tertiary structure in the peptides. The likely source 
of this difference is alterations in the peptide-membrane interactions, which also 
aids in explaining the differing propensities of the peptides to aggregate. In 
solution, rIAPP is prevented from aggregating largely by the conformational 
restraints imposed by the three proline residues [7, 8]. However, it is important to 
note that hIAPP with triple proline substitutions displays greatly reduced, but still 
detectable, aggregation [47]. This suggests that the charge on R18 and 
alterations in the N-terminus play some role in the relative aggregation 
propensity. Aggregation rates are greatly enhanced once the peptide is bound to 
the membrane due to the concentrating effect of restricting diffusion to a two 
dimensional surface and the restriction of angular motion [16, 51, 52]. Several 
features of the membrane-bound rIAPP act in concert to retard aggregation and 
the formation of toxic oligomers. First, the charge on R18 inhibits the deep 
insertion of the peptide into the membrane as seen for the rIAPP1-19 peptide [18, 
19]. Furthermore, the disordered C-terminus in rIAPP that is absent in rIAPP1-19 
compounds the difficulty of membrane insertion as hydrogen bonding of the 
peptide to solvent cannot be accommodated in the hydrophobic interior of an 
intact membrane. This difference in the C-terminal end of the peptide likely has 
the effect of altering the interaction of rIAPP with the membrane compared to 
rIAPP1-19. The likely result of this difference in the interactions of rIAPP, rIAPP1-19, 
hIAPP1-19, and most likely hIAPP with the membrane are alterations of the 




association of IAPP as discussed above. 
Significance of the structure for the normal biological activity of IAPP. IAPP 
belongs to the CGRP family of peptides that includes calcitonin-gene-related 
peptide (CGRP), calcitonin, adrenomodulin, and IAPP [53]. Although the 
sequences of these peptides are somewhat dissimilar, all the peptides in this 
family bind to common G-coupled protein receptors and produce similar effects in 
many tissues [54, 55]. Many of the peptides in this family such as human CGRP 
and calcitonin are also amyloidogenic and aggregate to form membrane-
disruptive oligomeric structures [56-59]. NMR studies on these peptides in 
detergent micelles have shown that these properties are apparently linked to 
common structural elements held among the family. All of the peptides in this 
family possess an amidated C-terminus, an amphipathic helix near the N-
terminus, a largely disordered C-terminus, and an N-terminal ring connected by a 
disulfide bond [60-63]. Two binding sites have been proposed for the binding of 
peptides of this family to the membrane-bound receptor: one near the membrane 
surface that would be consistent with the orientation found in this study for rIAPP 
and another requiring a more deeply inserted membrane orientation as found for 
hIAPP1-19 and hypothesized for hIAPP [60, 64, 65]. Relatively little is known 
about structure activity relationships for IAPP‟s normal biological action in 
comparison to its pathological aggregation. Experiments on truncated versions of 
calcitonin and CGRP (the closest homologue of IAPP) have shown that the 
formation of the amphipathic helix is sufficient for receptor binding but activation 




or reduction of the disulfide bridge results in CGRP binding to its receptor in an 
inactive conformation. A similar N-truncated rIAPP construct (rIAPP8-37) has been 
shown to act as an antagonist for rIAPP‟s effects on insulin secretion and 
carbohydrate and lipid metabolism [67-69]. Given the importance of the N-
terminal ring for the biological activity of IAPP, it would be interesting to further 
study the biological activity of IAPP in light of the structural differences in the N-
terminal ring shown here for rIAPP and IAPP1-19 and is hypothesized for hIAPP 
[70]. 
Several structural features that have been shown to be important for other 
members of this family are absent in the rIAPP structure. A β-turn centered on 
P34 has been shown to be important for the activity of the related calcitonin [60, 
71, 72] and CGRP peptides [62, 73, 74]. Similar β-turns have been shown to be a 
common feature for the activation of other peptide-activated G-coupled protein 
receptors [75]. This turn is absent in both the rIAPP and hIAPP structures, 
although the 20-29 fragment of hIAPP adopts a similar distorted type I β-turn that 
has been implicated in the binding of IAPP to glycolipids [42, 76, 77]. However, 
since considerable flexibility exists at this site it is possible that IAPP adopts the 
β-turn conformation in this region seen in its homologues upon binding to the 
IAPP receptor. A significant degree of mobility has also been detected by EPR at 
residues 21 and 22 for hIAPP bound to small unilamellar vesicles [14]. An 
interaction of the disordered C-terminus with the N-terminus has been invoked as 
contributing to the higher potency of salmon calcitonin over human calcitonin [60, 




away from the helix as in the human calcitonin structure, as indicated by the 
absence of medium- or long-range NOEs in this region [60]. 
3.6 CONCLUSION 
We have solved the first structure of rat IAPP in a membrane environment. 
By comparing the rIAPP structure with other toxic and nontoxic variants of IAPP, 
we have identified two structural features that correlate with the toxicity of the 
peptide. Rat IAPP is bound to the surface in a manner similar to the nontoxic 
rIAPP1-19 and low-pH hIAPP1-19 peptides and does not penetrate deeply into the 
micelle like the toxic neutral pH hIAPP1-19 peptide. The position of the N-terminal 
disulfide bridge has been identified as another factor that may modulate 
aggregation and toxicity. The nontoxic rIAPP structure has a relatively rigid N-
terminus that is bent toward the hydrophobic face of the amphipathic helix, 
whereas more toxic forms of IAPP have a more flexible N-terminus that is 
positioned away from the amphipathic helix. A comparison of the rIAPP structure 
to other homologous peptides that share the same receptors, hIAPP, and also 
fragments from hIAPP shows rIAPP does not possess the β-turn seen in these 
peptides that is required to activate the receptor, but this region is flexible and 
may form a β-turn upon binding to the receptor. Further structural studies on 
IAPP, in particular with respect to its normal biological activity, will be particularly 
useful in understanding the effects of this peptide. 
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CHAPTER 4. THE C-TERMINUS OF AMIDATED IAPP IS LARGELY HELICAL 
AT PHYSIOLOGICAL pH IN A MEMBRANE ENVIRONMENT : AN NMR 
STUDY 
This chapter is a version of a manuscript submitted to Biophys. J.3 
4.1 ABSTRACT 
 Human islet amyloid polypeptide is a hormone coexpressed with insulin by 
pancreatic beta-cells.  For reasons not clearly understood, hIAPP aggregates in 
type II diabetics to form oligomers that interfere with beta-cell function, eventually 
leading to the loss of insulin production. The cellular membrane catalyzes the 
formation of amyloid deposits and is a target of amyloid toxicity through 
disruption of the membrane‟s structural integrity. Previously, the structure of 
recombinant hIAPP has been solved in SDS micelles at acidic pH. However, the 
naturally expressed peptide has an amidated C-terminus not present in the 
recombinant form and aggregation into the fibrillar form primarily occurs at a 
neutral pH. Since the aggregation of hIAPP is highly influenced by electrostatic 
interactions, we determined the structure of hIAPP with an amidated C-terminus 
in SDS micelles at pH 7.3. Both structures have an overall kinked helix motif, with 
residues 7-17 and 21-28 in a helical conformation in both structures. However, 
unlike the previously solved structure, the C-terminus of amidated hIAPP is also 
structured, with a 310 dynamic helix from Gly33-Asn35. In addition, the angle 
between the N- and C-terminal helices is constrained to 85º instead of the free 
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rotation present in the structure of recombinant hIAPP. These changes allow a 
greater penetration of the peptide into the micelle surface, as shown by 
paramagnetic quenching studies, and are likely to play a role in its aggregation. 
4.2 INTRODUCTION 
Human Islet Amyloid Polypeptide (also known as amylin) is a 37 residue 
peptide hormone secreted from pancreatic β-cells (Figure 4-1). In its normal 
physiological role, hIAPP is associated with appetite suppression and, in 
conjunction with insulin, in maintaining proper glycemic levels [1]. However, a 
change in the cellular environment in the early stages of type II diabetes, poorly 
understood at present, causes it to aggregate into dense, insoluble fibrillar 
deposits that accumulate in the pancreas [2]. These proteinaceous deposits, 
known as amyloid, have a characteristic β-sheet secondary structure similar to 
those found in Alzheimer‟s, Parkinson‟s, Huntington‟s, and a variety of other 
degenerative disorders [3]. Like the amyloid deposits found in these diseases, 
hIAPP aggregates of various forms have been linked to cellular death and 
impairment of normal tissue functioning [4-6]. 
 
Figure 4-1. Primary sequence of the C-terminus-amidated human IAPP including 
the disulfide bridge between Cys2 and Cys7. 
 
One of the primary mechanisms by which hIAPP and amyloidogenic 
peptides in general cause cellular death is the disruption of the integrity of the 
cellular membrane [7]. Human islet amyloid polypeptide, but not the non-




integrity of the phospholipid membrane in both model membranes and in cells [8-
13].  The exact mechanism of membrane disruption is unknown but has been 
linked to peptide aggregation on the membrane surface [8, 11, 12]. Binding of 
hIAPP to lipid membranes also markedly accelerates the aggregation to fibril 
formation, a factor that is likely to be important in determining the final amount of 
amyloid deposition [14-16]. 
Human IAPP initially binds to the membrane in an α-helical state. Once 
bound to the membrane, aggregation of the peptide causes a cooperative 
conformational change from the helical conformation to the β-sheet amyloid form 
[17-20].  In order to gain a better insight in to this process, the structure of hIAPP 
bound to SDS micelles was recently solved [21]. In this system, hIAPP is 
monomeric and adopts a largely α-helical conformation, [21] in general 
agreement with the initial membrane-bound conformation of the peptide in other 
membrane types [18, 19]. More specifically, the structure was a single helix from 
residues 5-28, with the helix kinked near residues 18-22 and the stability of the 
helix decreasing towards the C-terminal end [21]. The peptide was found to be 
bound to the micelle surface with a slight penetration of the N-terminal helix into 
the detergent headgroup region [21].  
However, several differences exist between the conditions used to solve 
this structure and those likely to be encountered by hIAPP in the physiological 
setting. First, the studies were performed at an acidic pH of 4.6 [21]. A recent 
NMR study on a truncated version of hIAPP (hIAPP1-19) showed that protonation 




surface associated state [22]. This observed change in membrane topology with 
pH was linked with a greatly reduced potential of hIAPP1-19 to disrupt 
phospholipid vesicles, a phenomenon that was also observed for β-cell 
membranes as demonstrated by a H18R hIAPP1-19 mutant [9]. Further, the 
aggregation of hIAPP is strongly pH dependent [23, 24], with protonation of H18 
slowing the aggregation by a factor of ~4 [24]. The decrease in the aggregation 
potential of hIAPP at acidic pH is one factor that allows hIAPP to be safely stored 
in the secretory granule (pH ~5.5) in a presumably non-aggregated form [25]. 
Second, hIAPP is normally expressed with an amidated C-terminus that is 
essential for proper biological function [26].  The NMR study used a recombinant 
form of the peptide with a non-amidated C-terminus, altering the electrostatic 
interactions at the C-terminal end of the peptide [21]. This small change is 
significant for hIAPP as studies have shown that the free acid of hIAPP is 
significantly less amyloidogenic than the amidated version [27]. In addition, a 
recent study has shown relatively strong interactions between protonated His18 
and Tyr37, [28] which may partly be attributable to a salt bridge formation 
between His 18 and the C-terminus, an interaction that will not occur in the 
amidated peptide. Therefore, it is important to determine the structure of 
membrane-bound hIAPP under conditions more close to the physiological state. 
In this study, we have solved the high-resolution structure of C-terminus-
amidated hIAPP in SDS micelles and determined the membrane-binding 
topology with respect to the micelle at physiological pH. Our results indicate a 




disordered in the previous hIAPP structure but is ordered under the conditions 
employed in this study. 
4.3 MATERIALS AND METHODS 
4.3.1 Sample preparation. Human IAPP (hIAPP) was synthesized and purified 
by SynBioSci (Toronto, ON) with a disulfide bridge from residues Cys2-Cys7 and 
an amidated C-terminus. The peptide was dissolved in hexafluoroisopropanol to 
monomerize the preformed aggregates of hIAPP, and then lyophilized to remove 
the solvent. For NMR experiments, the sample was prepared by dissolving a 3 
mg of lyophilized peptide in 20 mM sodium phosphate buffer at pH ~7.3 
containing 10% D2O, 120 mM NaCl and 200 mM perdeuterated SDS (Cambridge 
Isotopes Laboratory) to a final peptide concentration of 2.5 mM. 
4.3.2 NMR Data Collection and Processing. All NMR experiments on SDS 
micelles containing hIAPP were performed at 25 °C using a 900 MHz Bruker 
Avance NMR spectrometer equipped with a triple-resonance cryogenic probe. 
After optimizing the experimental parameters using 1D 1H NMR spectrum of the 
sample, a 2D 1H-1H TOCSY spectrum was recorded with an 80 ms mixing time 
and 2D 1H-1H NOESY spectra were recorded at 100 ms and 300 ms mixing 
times in order to assign backbone and side-chain resonances. Complex data 
points were acquired for quadrature detection in both frequency dimensions of 
the 2D experiments. For all the spectra, zero-filling was applied in both 
dimensions to yield matrices of 2048 x 2048 points. Proton chemical shifts were 
referenced by setting the water peak at 4.7 ppm. All 2D spectra were processed 




Resonance assignments were done using a standard approach as reported 
elsewhere [30]. 
4.3.3 Structure Calculations. The final structural calculations were carried out 
with the CYANA 2.1 program package using simulated annealing in combination 
with molecular dynamics in torsion angle space.(31) NOE connectivities were 
used for the calculation of dihedral angle restraints [32]. Unambiguous long-
range NOE constraints were used during the first round of structural calculations 
to generate an initial low-resolution structure. The remaining ambiguous NOE 
cross-peaks were assigned in an iterative fashion by applying a structure-aided 
filtering strategy in repeated rounds of structure calculations [33]. A total of 500 
conformers were calculated using 8000 annealing steps for each conformer after 
complete assignment of resonances. The lowest 20 energy conformers were 
selected and visualized using MOLMOL [34]. 
4.3.4 Paramagnetic Quenching. 2D 1H-1H TOCSY spectra of hIAPP embedded 
in SDS micelles were recorded in the absence and in the presence of 0.8 mM 
MnCl2. All the other experimental conditions were the same as mentioned above. 
4.4 RESULTS 
4.4.1 3D Structure of hIAPP in SDS micelles. 2D 1H-1H TOCSY and NOESY 
spectra of hIAPP embedded in SDS micelles were used to assign the backbone 
and side chain resonances of the peptide. The deviation of the Hα chemical shifts 
from the corresponding values for a random coil structure (Hα chemical shift 




α-helical structure, Hα protons experience a shift to higher field corresponding to 
a negative deviation in the CSI plot. A negative deviation spanning 3 or more 
residues indicates the propensity for an α-helical conformation.  The CSI plot 
shows the propensity for a helix formation in two regions of the hIAPP, a longer 
helix in the region from Ala5 to Ser28 and a shorter helix from Ser34 to Tyr37 as 
shown in Figure 4-2. The chemical shift value for the Hα proton of Cys2 was not 
observed in the spectra, most likely due to a chemical exchange process.  
 
Figure 4-2. α-Proton chemical shift index measured from hIAPP embedded in 
SDS micelles. The CSI was calculated by subtracting the appropriate random coil 
chemical shifts reported in the literature. A CSI ≤ -0.1 is considered indicative of 
a helical conformation. 
 
The fingerprint region of the NOESY spectra obtained at a 300 ms mixing 
time is shown in Figure 4-3 with sequential assignment of residues. From the 
analysis of 2D NOESY spectra, we have assigned a total of 568 (446 short, 119 
medium and 3 long range) NOEs for hIAPP (Figure 4-4). The final 3D structure of 
the peptide is presented in Figure 4-5 (pdb id 2L86). The superposition of 




shown in Figure 4-5, while the superposition of all heavy atoms gives an RMSD 
of 1.09 ± 0.23 Å (see Table 4-1 for more structure statistics). Three helical 
domains are evident from the numerous dNN(i,i+1), dNN(i,i+2), dαβ(i,i+3), dαN(i,i+3) 
and dαN (i,i+4) NOE connectivities that are diagnostic of an α-helix as shown in 
Figure 4-5. Two of the helical domains extending from residues Cys7-Val17 
Table 4-1. Statistical information for the hIAPP structural ensemble. 
                                                                                                                          
Distance constraints            
                                            Total                                                                       
                                            Short (i – j ≤ 1)                                                           
                                            Medium (i – j = 2, 3, 4)                                                        





Structural statistics  
                                            Violated distance constrains 
                                            Violated angle constrains 
                                            RMSD of all backbone atoms (Å) 
                                                         Cys 7 – Tyr 37                                                          
                                            RMSD of all heavy atoms (Å) 





0.49 ± 0.17 
 
1.32 ± 0.27 
 
Ramachandran plot  
                                            Residues in most favored region (%) 
                                            Residues in additionally allowed region (%) 
                                            Residues in additionally allowed region (%) 
86.6 
10.8 
  2.6 
 
and Asn21-Ser28 are stable α-helices, while the third is a short dynamic 310-helix 
extending from Gly33 to Asn35. The two stable helices are separated by a turn 
from residues His18-Ser20. The break in the N-terminal α-helix at His18, also 
present in the previous NMR structure of the recombinant hIAPP [21], is 
confirmed by the absence of dαβ(i,i+3), dαN(i,i+3) NOEs from Leu16-Ser19 and 
His18-Ser20 that would be present if Leu16-Ser19 were in a helical conformation 
(Figure 4-4). Unlike the structure of the recombinant hIAPP, the second helix 
does not rotate freely about the first helix but is constrained in a bent 





Figure 4-3. The fingerprint region of 2D 1H-1H NOESY spectrum of hIAPP in SDS 
micelles showing sequential Hα - HN NOE connectivities. 
 
This constraint between the two helices can be attributed to the presence of 
dαN(i,i+2) and dαN(i,i+3) NOEs from V17 to S19 and also from V17 to S20 which 
limit the conformational space to the bent conformation observed in the structure 
(Figure 4-4).  
 
Figure 4-4. A summary of the sequential and medium range NOE connectivities 
for hIAPP in SDS micelles. The intensities of the observed NOEs are represented 
by the thickness of lines and are classified as strong, medium, and weak. 
 




observed in the structure of the recombinant hIAPP. The absence of dNN(i,i+3), 
dαβ(i,i+3), and dαN (i,i+4) NOEs in the spectra of recombinant hIAPP in this 
region,[21] as well as their presence in the current study, support this difference 
between the two structures. In particular, dNN(i,i+3) NOEs from Val32-Asn35 and 
Gly33-Thr36, a dαβ(i,i+3) NOE from Val32-Asn35, and a dαN (i,i+4) NOE from 
Thr30-Ser34 (Figure 4-4) indicate the existence of a helical conformation from 
Gly 33 to Asn 35, none of which were observed in the spectra of recombinant 
hIAPP [21]. The presence of dαN(i,i+2) NOEs spanning Thr30-Val32, Gly33-
Asn35, and Ser34-Thr36 indicates the formation of a 310-, rather than α-, helix 
(Figure 4-4). This contention is further supported by the observation of hydrogen 
bonds in the final structure between the backbone of Gly33 to Thr36 and Ser34 
and the C-terminal amide, an i to to i+3 pattern typical for 310 helices. 
 
Figure 4-5. High-resolution NMR structures of hIAPP in SDS micelles at 
physiological pH. Note that the N-terminal helix from C7-V17 is separated from 
the other helix from N21-S28 by a turn comprising of residues H18-S20 and the 
C-terminus has a short 310-helix comprising of residues G33-N35. 
 
4.4.2 Localization of hIAPP in SDS micelles. In order to find the orientation of 






quenching experiments using MnCl2 as a paramagnetic ion. Since Mn
2+ ions are 
less likely to penetrate into the hydrophobic interior of the micelle, only residues 
exposed to solvent experience the paramagnetic induced relaxation effect that 
results in broadening of the corresponding peaks. In the 2D TOCSY spectrum 
recorded in the presence of 0.8 mM MnCl2, most of the resonances in the finger 
print region disappeared as shown in Figure 4-6, indicating most of the residues 
of hIAPP are exposed to the solvent and the peptide is located close to the 
surface of the micelle. However, the Hα protons of T9, R11 and L12, the side 
chain peaks of K1, N3, Q10, R11, N14, and the amide protons of C2, A5-A13, 
F15-L16, S20, A25, S29, V32, T36 and Y37 are still observable but with a 
reduced intensity. These results indicate that the side chains of residues in the 
stable helical region Cys7-Val17, as well as some of the residues in the dynamic 
310-helical region Gly33-Asn 35, are most likely embedded into the head group 
region of the detergent. 
4.5 DISCUSSION 
 The structure of hIAPP in the physiological amidated form at neutral pH 
resembles that of the recombinant free acid at an acidic pH with two important 
differences (Figure 4-7). In the structure of Patil et al., IAPP is folded into a 
dynamic helix, kinked between residues 18-22, with a conformationally 
unconstrained C-terminal end from residues 30-37 [21]. Paramagnetic quenching 
data suggests the hIAPP free acid is partially immersed into the SDS micelle at 
acidic pH, with the folded N-terminal helix (residues 2-16) immersed to a greater 





Figure 4-6. 2D 1H-1H TOCSY spectra of hIAPP in SDS micelles at physiological 
pH in the absence (top) and presence (bottom) of 0.8 mM MnCl2. 
 
The helix-turn-helix conformation found in both structures is a common motif 
found in many of the high-resolution structures of amyloids bound to the 
detergent micelles, where an amphipathic helix is separated from a more polar 
helix by a short flexible region. In all these high-resolution structures there is a 
variable degree of conformational flexibility, as the location of the linker as well 
as length of the helical regions vary depending upon the experimental conditions 
[21, 35-38]. The location of the kinks in the structure in detergent micelles largely 
correlates with the location of the turns in the structure of the amyloid fiber [39-
43]. 
Although the overall helix-turn-helix motif of the previous structure is preserved, 





Figure 4-7. Overlay of the ensemble of NMR structures of hIAPP in SDS micelles 
solved at acidic pH (blue) and physiological pH (red). Note that the N-terminal 
helix (residues to 7 to 17) overlays quite well, while a substantial deviation is 
observed for the second helix from 21 to 28. 
 
this study. While the N-terminal α-helix of both the structures overlays well from 
Cys7-Val17 with a backbone RMSD of 0.48 ± 0.25 Å as shown in Figure  4-7, the 
second helix deviates significantly from each other.  At acidic pH, the helix from 
Asn22-Ser28 in the the hIAPP free acid wobbles about the N-terminal helix with 
an inter-helical angle of 30°C [21]. By contrast, the Asn21-Ser28 helix of C-
amidated-hIAPP at neutral pH is constrained to lie at an interhelical angle of 85°. 
The strongly bent aspect of the structure resembles those of hIAPP and the 
related pramlintide construct determined at neutral pH in fluorinated organic 
solvents, [24, 44] suggesting the kink in the helix is not enforced by membrane 
binding. In both structures the region of the peptide constrained by the disulfide 
ring is partially unstructured and pointing away from the hydrophobic side of the 







  In addition to the differences observed in the kink region of the peptide, a 
substantial difference exists at the C-terminal end. In our structure residues 
Gly33 to Asn35 at the C-terminal end of the peptide are in a 310 helical 
conformation, in comparison to the conformationally unconstrained C-terminus 
found in the structure of Patil et al [21]. The CD spectra of hIAPP at pH 4.6 and 
10.8 are similar, suggesting that the change in the protonation state of His18 is 
not responsible for the observed differences [21]. The formation of the 310
 helix 
from Gly33 to Asn35 is therefore most likely due to the change from an 
unprotected, negatively charged C-terminus to the amidated, uncharged variant 
present in the physiologically expressed peptide. The negatively charged free 
acid will unfavorably interact with the headgroup of SDS and negatively charged 
lipids, while the amidated version not only lacks this unfavorable interaction but 
also has the potential for favorable hydrogen bonding interactions with the 
detergent or lipid headgroup. As a consequence, the C-terminus interacts more 
strongly with the SDS micelle, penetrating deeper into the micelle as shown by 
the larger number of NOEs that survive paramagnetic quenching, particularly at 
the C-terminal end (see Figure 4-6). The change in the protonation state of His18 
may assist in this process, as His18 once deprotonated loses its electrostatic 
interactions with the negatively charged head group of SDS micelles. The loss of 
this anchoring point may allow a greater penetration into the membrane, as was 
observed with the 1-19 fragment of hIAPP [9, 22]. 
 Several lines of evidence point to the importance of the C-terminal end of 




independently form amyloid deposits [45]. Second, mutations at the C-terminal 
can adversely affect the kinetics of amyloid formation. For instance, mutation of 
Asn31 to Leu or Asn35 to Leu is sufficient for a three-fold decrease in the 
fibrillogenesis rate, [46] while mutations of Asn31 to Ser or Val32 to Ala abolish 
amyloid formation [47]. Third, the hIAPP free acid aggregates significantly slower 
(1/9 the rate) than the amidated variant, suggesting electrostatics at the C-
terminal end plays a key role in aggregation [27]. Fourth, the entire C-terminus is 
incorporated into the amyloid fiber in the current structural model of hIAPP 
amyloid fibers, indicating interactions of the C-terminal with the N-terminal 
stabilize the final structure [41]. Finally, the N-terminal regions of hIAPP and the 
nonamyloidogenic and nontoxic rat IAPP variant are similar, with most of the 
differences in the structure concentrated at the C-terminal end [22, 48]. Taken 
together, these findings raise the possibility that, while the C-terminus is not 
strictly essential for amyloid formation by hIAPP, [49] its conformation can 
significantly modulate the kinetics of amyloid formation (see Figure 4-8 for a 
possible model).  
 
Figure 4-8. A possible schematic model for the aggregation of hIAPP in the 
presence of lipid membranes. (A) hIAPP initially binds to the membrane in a 
helical conformation. (B) Once bound to the membrane, hIAPP aggregates on 
the membrane surface to form helical bundles (C) Aggregation of the peptide 
causes a conformational change in the less structured C-terminus to the β-sheet 




triggers a corresponding conformational change at the N-terminus, producing the 
final amyloid fiber. 
 
 The existence of a structured C-terminus is significant for a structural 
interpretation of both membrane-mediated and membrane-free aggregation of 
hIAPP. The transition from a conformationally unconstrained monomeric peptide 
to the highly ordered amyloid supermolecular complex is entropically disfavored. 
For this reason, amyloid formation from conformationally unconstrained 
monomers is frequently kinetically inaccessible, despite the overall favorable free 
energy change associated with amyloid formation for hydrophobic sequences 
[50]. Partially structured intermediates can reduce the entropic cost of the highly 
disfavored initial step of amyloid formation by favorably positioning aggregation 
prone regions to interact with each other. In particular, there is evidence for a 
mechanistic role for helical intermediates in amyloid aggregation [3, 51]. Helical 
intermediates have been directly observed for some amyloidogenic proteins and 
have been indirectly inferred for others from mutational analysis and solvent 
perturbation studies [52, 53]. Utilizing this fact, inhibitors have been constructed 
to prevent amyloid formation by either excessively destabilizing or overstabilizing 
the helical state [54, 55]. 310 helices are particularly suited for undergoing a helix 
to beta sheet transition due to the relative similarities in the phi/psi torsion angles 
between the beta-sheet and 310 helix conformations and the relative ease of 
partially unfolding a 310  helix compared to the α-helix conformation [3]. 
4.6 CONCLUSION 
In conclusion, we have solved the structure of hIAPP with an amidated C-




terminus hIAPP solved at pH 4.9, both the structures have an overall kinked helix 
motif, with residues 7-17 and 21-28 in a helical conformation in both structures. 
However, the C-terminus of amidated hIAPP is structured, with a 310 dynamic 
helix from Gly33-Asn35, which was not observed in the structure of recombinant 
hIAPP solved at an acidic pH. In addition, the angle between the N- and C-
terminal helices is constrained to 85º instead of the free rotation present in the 
structure of recombinant hIAPP. These differences observed in our structure 
might play an important role in the aggregation process of hIAPP. 
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CHAPTER 5. NMR STRUCTURE IN A MEMBRANE ENVIRONMENT 
REVEALS PUTATIVE AMYLOIDOGENIC REGIONS OF THE SEVI 
PRECURSOR PEPTIDE PAP248-286 
This chapter is a version of a manuscript published in J. Am. Chem. Soc. (2009) 
131, 17972-17979.4 
5.1 ABSTRACT 
 Semen is the main vector for HIV transmission worldwide. Recently, a 
peptide fragment (PAP248-286) has been isolated from seminal fluid that 
dramatically enhances HIV infectivity by up to 4-5 orders of magnitude. PAP248-
286 appears to enhance HIV infection by forming amyloid fibers known as SEVI, 
which are believed to enhance the attachment of the virus by bridging 
interactions between virion and host-cell membranes. We have solved the 
atomic-level resolution structure of the SEVI precursor PAP248-286 using NMR 
spectroscopy in SDS micelles, which serve as a model membrane system. 
PAP248-286, which does not disrupt membranes like most amyloid proteins, binds 
superficially to the surface of the micelle, in contrast to other membrane-
disruptive amyloid peptides that generally penetrate into the core of the 
membrane. The structure of PAP248-286 is unlike most amyloid peptides in that 
PAP248-286 is mostly disordered when bound to the surface of the micelle, as 
opposed to the α-helical structures typically found of most amyloid proteins. The 
highly disordered nature of the SEVI peptide may explain the unique ability of 
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SEVI amyloid fibers to enhance HIV infection as partially disordered amyloid 
fibers will have a greater capture radius for the virus than compact amyloid fibers. 
Two regions of nascent structure (an α-helix from V262-H270 and a dynamic 
α/310 helix from S279-L283) match the prediction of highly amyloidogenic 
sequences and may serve as nuclei for aggregation and amyloid fibril formation. 
The structure presented here can be used for the rational design of mutagenesis 
studies on SEVI amyloid formation and viral infection enhancement. 
5.2 INTRODUCTION 
Despite the rapid progress of the AIDS pandemic, the HIV virus is a 
surprisingly weak pathogen in vitro with only <0.1% of virus particles succeeding 
in infecting a host cell [1, 2]. Emerging evidence suggests that difficulties in virus 
attachment to the host cell in vitro, rather than intrinsic deficiencies in viral 
particles, are the source of this low infection rate. Because the half-life of free 
virions of HIV is very short in comparison to the probability of a virion randomly 
encountering the appropriate receptor, most virions will decay before initiating a 
successful infection cycle unless they can rapidly attach to the cell membrane 
surface where the search for the cell receptor proceeds by inherently more 
efficient two-dimensional diffusion [3, 4]. Viral attachment to the cell surface entry 
of the virus into the host cell therefore appears to be the primary barrier to HIV 
infection in vitro [5]. 
The difference between in vitro and in vivo infection rates suggests this 




vitro but present in vivo may be responsible for this difference. A clear candidate 
has emerged from a recent screening of a large library of peptides and low 
molecular weight proteins (<50 kDa) found in human semen. This screening 
identified SEVI (semen-derived enhancer of viral infection), a naturally occurring 
39 amino acid fragment from prostatic acid phosphatase (PAP) that enhanced 
the rate of HIV infection dramatically across a broad range of HIV phenotypes [6-
8]. 
Limiting dilution assays showed a truly remarkable enhancement by 4-5 
orders of magnitude when HIV viral loads more closely resembling the actual 
conditions during sexual transmission were used, with only 1-3 virions necessary 
to establish a persistent infection in CEMx M7 dendritic cells in the presence of 
SEVI [6]. Furthermore, SEVI‟s ability to increase viral infectivity is not limited to 
the HIV virus, as it also exerts a similar effect on the XMRV retrovirus [9]. 
Because the structures of SEVI are not known in any form, it is difficult to 
make predictions about the interactions of SEVI with the cell membrane that 
facilitate HIV viral attachment. Some degree of aggregation of the peptide is 
necessary for activity as freshly prepared, monomeric solutions of SEVI are 
ineffective at promoting viral infectivity and the enhancement of HIV infectivity 
increases with time as SEVI is incubated in solution [6]. It has been established 
that SEVI is an amyloidogenic peptide and that amyloid fibers of the peptide are 
more effective than the monomeric peptide in promoting HIV cell binding and 
membrane fusion [6]. This is in agreement with previous studies that have shown 




amyloidogenic proteins, such as Aβ and α-synuclein [10]. While some degree of 
oligomerization seems to be a requirement for SEVI-enhanced infectivity, 
amyloid formation does not seem to be an absolute requirement for the 
enhancement of HIV infection by PAP248-286 as it occurs well before the formation 
of amyloid fibers [6].  
These interactions are likely to be highly dependent on specific structural 
details as other amyloid proteins that share the same gross cross-β sheet 
structure as SEVI show a much lower enhancement of infectivity. To understand 
the mechanism by which SEVI promotes the bridging of viral and host cell 
membranes, we have solved the high-resolution structure of the SEVI precursor 
PAP248-286 in a membrane mimicking environment (SDS micelles) using NMR 
spectroscopy. The structure of PAP248-286 possesses an unusual amount of 
disorder as compared to other amyloid proteins, which may explain the much 
greater ability of SEVI to enhance HIV infection as compared to amyloid fibers 
formed from other proteins [6]. From the structure and bioinformatic analysis of 
the PAP248-286 sequence, we have also identified a putative amyloidogenic region 
of the PAP248-286 sequence. 
5.3 MATERIALS AND METHODS 
5.3.1 NMR Sample Preparation. SEVI refers to the amyloid form of peptides 
derived from fragments of prostatic acid phosphatase (PAP). Of these peptides, 
the fragment PAP248-286 was chosen for this study, as amyloid fibers formed from 
PAP248-286 are the most effective at enhancing HIV infection. The PAP248-286 




Because the large size of the amyloid form of the peptide precludes its study by 
solution NMR, peptide aggregation must be prevented for the duration of the 
experiment to obtain a high-resolution structure of the peptide. The removal of 
preformed aggregates of the peptide that can act as nuclei for further peptide 
aggregation is essential to arrest this process; accordingly, the peptide was 
dissolved first in a strongly disaggregating 1:1 solution of trifluoroacetic acid 
(TFA) and hexafluoroisopropanol (HFIP) at a concentration of 5 mg/mL to break 
up preformed amyloid fibers [11]. The TFA/HFIP solution was evaporated by a 
stream of nitrogen gas, and the resulting film was redissolved in pure HFIP at a 
concentration of 2 mg/mL. HFIP was removed by lyophilization under high 
vacuum for 24 h. Samples were prepared for NMR measurements by dissolving 
3.4 mg of lyophilized peptide in 20 mM phosphate buffer at pH 7.3 containing 
10% D2O, 120 mM NaCl, and 200 mM perdeuterated SDS (Cambridge Isotopes 
Laboratory) to a final concentration of 2.5 mM. The choice of SDS micelles, 
neutral pH, and the addition of 120 mM NaCl was based on previous 
experiments showing the electrostatic nature of PAP248-286 membrane binding 
and the ability of PAP248-286 to cause substantial vesicle aggregation, particularly 
at acidic pH [11]. Samples prepared with zwitterionic DPC 
(dodecylphosphocholine) micelles aggregated rapidly and gave rise to a very 
broad and weak signal, while samples prepared without 120 mM NaCl displayed 
poorer resolution and showed visible aggregation within 24 h. 
5.3.2 NMR Data Collection and Processing.  All NMR spectra of PAP248-286 




Avance NMR spectrometer equipped with a TXI cryoprobe. Backbone and side-
chain assignment of peptide was achieved using 2D 1H-1H TOCSY (total 
correlation spectroscopy) recorded at a 80 ms mixing time and 2D 1H-1H NOESY 
(nuclear Overhauser enhancement spectroscopy) recorded at 100 and 300 ms 
mixing times. Both spectra were recorded using 16 scans and 512 points in the 
indirect dimension, with a recycle delay of 1.5 s. Complex data points were 
acquired for quadrature detection in both frequency dimensions for the 2D 
experiments. All spectra were zero-filled in both dimensions to yield matrices of 
2048 x 2048 points. Proton chemical shifts were referenced to the water proton 
signal at 4.7 ppm. All 2D spectra were processed using NMRPIPE and TopSpin 
software and analyzed using SPARKY [12, 13]. Resonance assignments were 
carried out using a standard approach reported elsewhere [14]. 
5.3.3 Structure Calculations. Structure calculations were performed using the 
X-PLOR-NIH program. A total of 286 NOEs, derived from the NOESY acquired at 
300 ms mixing time, were categorized into three distance categories based on 
the cross-peak volumes obtained from SPARKY analysis: strong (1.8-2.9 Å), 
medium (1.8-4.5 Å), and weak (1.8-6.0 Å). These restraints were further used in 
the structure calculations: 145 restraints were intraresidue, and 141 were inter-
residue NOEs (Table 5-1). The torsion angle restraints were obtained from the 
TALOS program using the Hα chemical shift values [15].  An extended structure 
of PAP248-286 was used as a starting point for the hybrid molecular dynamics 
simulated annealing (SA) protocol at a temperature of 4000 K for the generation 




used in the calculations. Subsequently, these structures were refined using a 
further SA step and energy minimization. The final refinement was carried out 
using the refine_gentle.inp protocol, which gradually introduces the van der 
Waals radii. The few ambiguous angles found in the loop region were assigned 
an additional 60° of conformational freedom as compared to their predicted 
values. Out of the 100 structures generated, an ensemble of eight conformers 
with low RMSD was selected for further analysis. The covalent geometry of the 
conformers generated was analyzed using PROCHECK_NMR [18]. 
Table 5-1. Statistical information for the PAP248-286 structural ensemble. 
                                                                                                                           
Distance constraints            
                                            Total                                                                       
                                            Intra-residual                                                            
                                            Inter-residual                                                           
                                            Sequential (i - j = 1)                                                






Structural statistics  
                                            NOE violations (Å) 
                                            Dihedral angle restraint violations (º) 
                                            RMSD for bond deviations (Å) 
                                            RMSD for angle deviations (º) 
                                            RMSD of all backbone atoms (Å) 
                                                         Val 262 – His 270 
                                                         Pro 278 – Leu 283 
                                            RMSD of all heavy atoms (Å) 
                                                         Val 262 – His 270 
                                                         Pro 278 – Leu 283 
 
0.0318 ± 0.0045 
0.7816 ± 0.1550 
0.0024 ± 0.0003 
0.4037 ± 0.0160 
 
0.15 ± 0.05 
0.74 ± 0.43 
 
0.57 ± 0.12 
1.60 ± 0.60 
Ramachandran plot  
                                            Residues in most favored region (%) 
                                            Residues in additionally allowed region (%) 
                                            Residues in additionally allowed region (%) 
                                            Residues in disallowed region (%) 
65.8 
29.8 
  3.7 
  0.7 
 
5.4 RESULTS 
5.4.1 Assignments, Constraints and NMR Structure. The structure of PAP248-
286 in SDS micelles was determined using solution NMR through 2D 
1H-1H 
TOCSY and NOESY data collected as mentioned in the Materials and Methods. 




PAP248-286. In an effort to optimize spectral resolution and sensitivity, several 1D 
1H chemical shift spectra were acquired over a temperature range of 25-45 °C, 
and the best compromise between sensitivity and resolution was found to be 
near 37 °C. 
The 2D 1H-1H NOESY spectra display numerous, relatively well-resolved 
cross-peaks, with a significant degree of spectral dispersion in the amide region 
indicating the presence of at least a partial degree of secondary structure 
throughout the peptide (Figure 5-1). This is an indication of secondary structure  
 
Figure 5-1. The fingerprint region of a 2D 1H-1H NOESY spectrum of SDS 
micelles containing PAP248-286 showing NOE connectivities among Hα nuclei. 
 
formation in the peptide, as a completely disordered structure would have both 
poor chemical shift dispersion due to the similarity of chemical shift values in the 
random coil state and poor NOE cross-peak intensity due to the high mobility of 




dαHNH(i,i+4), and dαHβH(i,i+3) NOE connectivities along with negative chemical 
shift indices provide unequivocal evidence for helical structure (Figures 5-2 and 
5-3). Similarly, the CD spectra of PAP248-286 in SDS micelles and trifluoroethanol 
solutions exhibit the double minima at 208 and 222 nm characteristic of partial α-
helical content. The remainder of the peptide has chemical shift index values 
consistent with disordered conformations, although the NOE crosspeak intensity 
pattern, which is more sensitive to transient structure formation, shows strong 
sequential dNHNH(i,i+1) peaks indicative of transient α-helical or β-sheet 
formation. 
 
Figure 5-2. NOE intensity plot for the amino acid residues of PAP248-286 showing 
the NOE connectivity among residues. Thicker lines correspond to stronger NOE 
intensities. 
 
To create the structure of PAP248-286, all NOEs were converted into 
distances and modeled using the classical simulated annealing protocol built in 
XPLOR-NIH. Out of the 100 refined PAP248-286 structures, 26 did not have NOE 




deviate from ideality by a RMS difference of >0.01 Å, or have bond angles that 
deviate from ideality by a RMS difference of >2°. Out of the structures that 
passed the acceptance criteria, an ensemble of eight conformers was further 
selected for the final analysis as a representation of the transient structure 
formed by the disordered PAP248-286 on the micelle. Statistical information on the 
peptide structure along with a summary of the backbone and side-chain NOEs 
used for secondary structure assignment is provided in Table 5-1 and Figure 5-4.  
 
Figure 5-3. α-Proton chemical shift index (CSI) for PAP248-286 showing the 
disordered N-terminal end (CSI near zero) and the central and C-terminal helical 
regions (CSI < -0.1). The Hα chemical shift of K272 was not detected (red). The 
CSI was calculated by subtracting the Hα chemical shifts values measured for 
the peptide from the random coil shifts values for the respective amino acid 
reported in the literature. 
 
The secondary structure representation of PAP248-286 from these eight 
conformers is shown in Figure 5-5A. The structure of the PAP248-286 peptide can 
be separated into three distinct regions: a highly flexible N-terminal region (G248-




region (M271-Y286) containing a short 310 or α-helix (S279-L283). The RMSD for 
the C- and N-terminal ends is very large, reflecting a high degree of disorder in 
these regions. The central region from V262-H270 is more ordered, and a 
superposition of the eight low-energy conformers gives an RMSD of 0.15 ± 0.05 
Å for the backbone atoms from V262-H270, and an RMSD of 0.57 ± 0.12 Å for all 
heavy atoms. Analysis of the Ramachandran plot, for the final eight conformers 
of the PAP248-286, shows that 65.8% of the residues fall in the most favored 
region, while the rest of the residues fall in the additionally allowed (29.8%), 
generously allowed (3.7%), and disallowed (0.7%) regions of the plot as shown in 
Figure 5-6. 
 
Figure 5-4. Histogram of the number of NOEs detected versus the residue 
number showing the number of intraresidue, sequential (i - j = 1), and medium 
range (i - j = 2, 3, 4) NOEs detected. Long-range (i - j > 4) NOEs were not 
observed. 
 
5.4.2 Positioning of the PAP248-286 in the Micelle. The paramagnetic quencher 




signal intensities of the nuclei that are in close proximity to the Mn2+ ion are 
decreased due to the increase in the relaxation rate of the nuclei. Because 
manganese ions cannot penetrate into the hydrophobic interior of the micelle, 
changes in signal intensity reflect the exposure of the amino acid residues of the 
peptide to the solvent. To identify the exposure of specific residues to solvent 
more precisely, 2D 1H-1H TOCSY spectra were used to monitor the changes in 
the chemical shift of the α-proton peaks after the addition of 0.8 mM MnCl2. It is  
 
Figure 5-5. (A) Secondary structure representation of an overlaid ensemble of 
NMR-derived conformers for PAP248-286 showing the helical region from V262-
H270, the highly flexible N- and C-termini, and the short helix from S279-L283. 
(B) Secondary structure representation of PAP248-286 extracted from the crystal 
structure of human PAP. In the crystal structure, residues L283-Y286 are in a β-
sheet conformation, while residues K251-I277 are in a helical conformation with a 
distortion at G261. (C) All-atom representation of the PAP248-286 conformational 
ensemble. 
 




(0.8 mM) concentration of Mn2+, except the α-protons of Ile 249 and Lys 251 and 
the β-protons of His 250 as shown in Figure 5-7. The near complete quenching of 
the residues of PAP248-286 is in contrast to other amyloidogenic peptides, which 
are bound to the surface of detergent micelles but show only a partial reduction 
in the peak intensity after the addition of as much as 1.2 mM MnCl2, and 
suggests the depth of penetration of PAP248-286 is significantly less [19, 20]. 
Partial rather than complete quenching of the residues near the N-terminus of the 
peptide suggests this cluster of residues is either buried further into the micelle 
than the remainder of the peptide or the mobility of these residues is altered so 
that the rotational reorientation time of these residues is shorter than the electron 
spin relaxation time [21-23]. 
 
Figure 5-6. Ramachandran plot showing the phi and psi angles for the ensemble 






Like many amyloidogenic short peptides and some amyloidogenic 
proteins, monomeric PAP248-286 is predominantly unstructured in solution. 
However, PAP248-286 is most active in the form of large aggregates with the 
characteristic β-sheet conformation of amyloid proteins (SEVI fibers). The 
structure of the final SEVI product is an obvious target for therapeutic 
intervention to block the action of SEVI, but the structures of intermediates along  
 
Figure 5-7. Fingerprint region of a 2D 1H-1H TOCSY spectrum of SDS micelles 
containing PAP248-286 after the addition of 0.8 mM MnCl2. The complete 
quenching of almost all peaks indicates that the peptide is well exposed to the 




the aggregation pathway of PAP248-286 may ultimately be just as fruitful as 
therapeutic targets. The significance of the intermediate state is due to the 
energetics of the aggregation process; amyloid fibers are thermodynamically very 
stable but are kinetically difficult to form due to the low probability that multiple 
aggregation prone segments will align in the correct orientation required for the 
precise self-assembly of the very ordered amyloid fiber. For this reason, 
aggregation of completely disordered proteins usually gives rise to amorphous 
aggregates rather than structured oligomers, [24-26] a fact that has been 
exploited by small molecule inhibitors that stabilize the disordered state of the 
monomer and divert aggregation from potentially toxic protofibrillar species to 
nontoxic amorphous aggregates [8, 27]. Preorganization of the monomeric state 
can overcome some of the difficulties associated with self-assembly by restricting 
the degrees of freedom of motion in the native state and aligning aggregation-
prone sites in the molecule in the proper orientation for intermolecular 
association [28, 29]. 
Taken these considerations into account, it can be seen that knowledge of 
the conformational preferences of the monomeric state of an amyloidogenic 
peptide can give substantial insight into the pathways of aggregation and 
eventual structure of the amyloid fiber [19, 20, 30-32]. However, the transient 
structure present in intrinsically disordered proteins is difficult to detect 
experimentally. Amyloidogenic proteins, particularly unstructured ones, are 
notoriously difficult to crystallize. The structural investigation of largely 




dispersion and the structural heterogeneity of the ensemble, which gives rise to 
substantial line-broadening due to conformational exchange among members of 
the ensemble on the submillisecond timescale [33]. The most structured regions 
of the peptide, which are the regions of most interest for the reasons mentioned 
above, are usually the victim of the most severe line-broadening. Another serious 
complication is the aggregation of the peptide, which severely aggravates the 
line-broadening due to conformational exchange and severely limits the 
observation time available before the aggregated protein is too large for solution 
NMR experiments. These limitations can be partially overcome by using 
trifluoroethanol or hexafluoroisopropanol solvent systems, which stabilize helical 
states of the peptide and reduce or eliminate aggregation at high concentrations 
[34-37]. The structure-promoting solvents are used to stabilize transient 
structures in the natural conformational ensemble, which is overall disordered 
[38]. However, the use of these solvent systems can be questioned as they can 
give rise to artificial levels of structure that are not present in the biological 
system [39-42]. 
Many of these limitations can be overcome by the use of detergent 
micelles to stabilize the monomeric protein, which offer a more biologically 
relevant environment than organic solvents as amyloid proteins are often found 
in intimate association with cellular membranes and many of their biological 
effects derive from this association [43-49]. SEVI in particular is thought to act by 
binding to the cell membrane surface and neutralizing the natural repulsion that 




mixtures of organic solvents and water, detergent micelles are heterogeneous 
like real cell membranes, having a hydrophobic core similar to the phospholipid 
bilayer and a polar interface between the micelle and solution. Detergents also 
have the additional advantage of trapping the aggregation-prone protein in a 
monomeric state due to the small size of the detergent micelle and the large 
electrostatic repulsion that exists between each micelle. This property is essential 
for limiting the rapid loss of signal due to aggregation of the peptide. 
PAP248-286 is largely disordered on the membrane surface, unlike many 
amyloid peptides. PAP248-286 binds to the surface of the SDS micelle in a largely 
disordered manner. The complete quenching of the signal of almost every 
residue at a relatively low concentration of Mn2+ suggests the binding of PAP248-
286 is almost entirely electrostatic, as previously inferred based on differential 
scanning calorimetry and the loss of PAP248-286 infection promoting activity in 
mutants lacking cationic residues [7, 11]. The superficial binding of PAP248-286 to 
the surface may explain the apparent lack of toxicity of PAP248-286 as the ability of 
amyloid peptides to disrupt membranes is frequently correlated with the 
penetration of the peptide into the hydrophobic part of the bilayer membrane [6, 
19, 20, 50, 51]. 
Most unstructured amyloidogenic peptides readily adopt an α-helical 
conformation when bound to membranes due to the amphipathic and 
hydrophobic nature of most amyloidogenic sequences. A common motif among 
amyloid peptides bound to detergent micelles is the helix-turn-helix motif, in 




flexible linker region. Most high-resolution structures of amyloidogenic peptides 
bound to detergent micelles show some variation of this motif, although a 
considerable degree of conformational flexibility is present in most of the 
peptides as the location of the linker region and the length of the helical regions 
of the peptide can vary substantially depending on the experimental conditions 
[52-55]. The structure of PAP248-286 is consistent with this general trend; however, 
the helical content is lower than other amyloid peptides, and the structure is 
dominated by long flexible regions joining short helices rather than by the well-
defined helices separated by short linker regions that are typical of other amyloid 
peptides. 
While the α-helical regions of the membrane-bound monomer of amyloid 
peptides are not found in the final amyloid product, regions that are disordered in 
the membrane-bound state frequently remain so throughout the aggregation 
pathway. For example, the N-terminus of Aβ1-42 and the C-terminus of α-
synuclein are disordered in both SDS micelles and in the structure of the amyloid 
fiber [56-61]. However, the disordered regions of these peptides are composed of 
negatively charged residues and not poised to interact favorably with the 
negatively charged cell membrane. On the other hand, the disordered N-terminus 
of PAP248-286 has a high percentage of positively charged lysine and arginine 
residues, which have a high affinity for surface of cell membranes. If the 
conformational flexibility and superficial electrostatic membrane binding found in 
monomeric PAP248-286 is also present in the structure of the membrane-bound 




proficiency of SEVI among amyloid proteins to enhance HIV infection. Flexible, 
highly charged cationic polymers like polylysine share SEVI‟s ability to enhance 
retroviral infection rates and share many common characteristics with the 
structure and membrane binding mode proposed here [11, 62, 63]. Like PAP248-
286, these polymers bind exclusively electrostatically to the membrane surface 
without penetration into the headgroup region, undergo helix-to-β-sheet 
transitions, and retain a considerable amount of flexibility when bound to the 
surface [64-66]. Disordered regions frequently have higher interaction rates than 
structured regions in proteins because the interaction volume (radius of capture) 
is larger for the disordered state than a compact, folded one [67, 68]. This is 
especially true if, like the association of proteins with lipids, binding is based on 
multiple weak, nonspecific interactions rather than a single specific interaction 
site [69]. Although a considerable degree of conformational reorganization is 
required to form the SEVI amyloid fiber, an unusual degree of disorder in the 
SEVI amyloid fiber may facilitate the membrane bridging interactions implicated 
in the enhancement of HIV infection by both SEVI and polylysine [68]. In addition, 
disordered regions in the amyloid fiber may facilitate the endocytosis of SEVI 
fibers. Many endocyotic proteins have extensive disordered regions, which 
appear to allow the capture of endocyotic nucleation factors across a large 
cytosolic volume [69]. A high degree of disorder in the SEVI amyloid fiber would 
likely enhance the rate of endocyotic internalization relative to other amyloid 
fibers, which internalize the HIV virion if it is bound to the SEVI fiber at the time 




mutagenesis work has been done [6, 7]. Further structural work on the SEVI 
amyloid fiber is likely to yield informative insights into the mechanism of HIV 
enhancement by SEVI and serve as a test of this hypothesis. 
Nascent helical structure in A274-I284 and V262-H270 may nucleate 
amyloid formation. Two regions of nascent helical structure may be nucleation 
sites for amyloid formation. The first region consists of a stable, regular α-helix 
extending from V262 to H270, and the second region consists of two dynamic or 
transient α- or 310 helices extending from A274-Q276 and Y280-I284 separated 
by a kink or distortion at residues I277-S279. The propensity for helical 
conformations in these regions may be essential for fiber formation, as a helix to-
β-strand transition is a common intermediate step in the amyloidogenesis of 
many amyloid proteins [30, 71]. The importance of helical intermediates in 
amyloid formation can be seen by the fact that the induction of helical structure 
through either the addition of a helix-promoting solvent or by membrane binding 
can dramatically enhance the rate of amyloidogenesis [71]. Mutational analyses 
of amyloid proteins with helical intermediates have shown that the helical 
intermediate should be metastable to efficiently promote β-strand formation. The 
stability of the helices in these regions may be critical for determining the ultimate 
rate of amyloidogenesis; if the helices are excessively stabilized by mutations in 
the sequence or by helix stabilizing drugs, the peptide can be kinetically trapped 
as a helical intermediate; conversely, a very unstable helix is insufficiently 
populated to impact the kinetics [72, 73]. 




suggests the nascent, dynamic helix at the C-terminus is essential for 
amyloidogenesis. Analyses of truncated versions of the PAP248-286 peptide have 
shown that deletions at the C-terminal end of the peptide in the region of the 
dynamic helix significantly reduce both amyloid formation and HIV promotion [6]. 
On the other hand, deletions at the N-terminal end, which is disordered in the 
NMR structure, have little effect. The metastable 310 helices that are present in 
some of the structures at the C-terminus are particularly suited for promoting 
intermolecular interactions and β-strand formation [30]. Because of the more 
extended conformation of the 310 helix as compared to an α-helix, the grooves of 
the 310 helix are larger and more easily accommodate the side-chains of another 
peptide. Furthermore, the β-turns that comprise the 310 helix are less stable than 
the α-helix and can be easily destabilized to form β-strands, [30] as shown by the 
crystal structure of PAP in which L283-Y286 is part of a β-strand on the surface 
of the protein [74]. 
The proposed amyloid nucleation sites are consistent with predictions of 
amyloidogenic regions. The increasing number of known amyloidogenic 
proteins has made possible the use of bioinformatic tools to predict 
amyloidogenic regions within proteins. The AGGRESCAN algorithm uses the 
inherent aggregation propensities of individual amino acids determined from 
mutational data on the Aβ peptide to find “hot spots”, short (∼5 residue) stretches 
of amino acid that serve as nucleating centers for amyloid formation [75, 76]. A 
color-mapped representation of the aggregation propensity from AGGRESCAN 




predictions of AGGRESCAN substantially match the helical regions of the NMR 
structure. AGGRESCAN predicts two aggregation “hot spots” in PAP248-286: 
G260-E266, which is approximately within the V262-H270 helical region, and 
K281-Y286 in the area of both the dynamic helix at the C-terminal end and the 
L283-Y286 sequence identified by activity studies on truncated peptides. The 
PASTA algorithm uses pairwise energy functions to determine the probability that 
a given stretch of residues can be in a parallel or antiparallel β-strand [77, 78]. 
Similar to the prediction of AGGRESCAN, PASTA predicts that residues 262-270 
are prone to form parallel β-sheets (energy score of -6 for residues 262-270 in a 
parallel alignment; stretches of residues in the β-sheet conformation in known 
fiber structures generally have a score of >4). 
 
Figure 5-8. Prediction of the amyloidogenic propensity of the PAP248-286 
sequence by AGGRESCAN. Red, orange, and gray colors indicate regions of 
high, moderate, and low amyloidogenic propensity, respectively. 
 
Because amyloid formation is almost always deleterious to a protein‟s 
normal function and general cellular health, there is substantial evolutionary 
pressure against amyloid formation. One method of preventing amyloid formation 
is to flank particularly amyloidogenic sequences with “gatekeeper residues”, 




either strong β-sheet breakers (glycine or proline residues) or highly charged 
sequences that enhance the electrostatic repulsion between proteins and 
therefore minimize aggregation [79]. The ordered 262-270 region of PAP248-286 
fits this pattern, being terminated on the N-terminal side by a double glycine 
repeat (GG) and flanked by a highly charged sequence (QKEK) nearby. 
Similarly, the C-terminal side of this sequence is flanked by a proline residue 
(P278) and a nearby lysine repeat (KK), which would also serve to limit the 
aggregation of the Y280-Y286 amyloidogenic region. This pattern of gatekeeper 
residues is conserved in all PAP sequences determined so far, suggesting that 
one of the functions of these residues is to limit the propensity of PAP to 
aggregate. The observation that PAP248-286 with all of the cationic amino acids 
mutated to alanine has a higher tendency to aggregate gives some support to 
this hypothesis [7]. 
5.6 CONCLUSION 
 We have solved the first high-resolution structure of the SEVI precursor 
peptide PAP248-286 as a first step toward understanding the structural factors that 
drive PAP248-286 to form the amyloid fibers that are identified as the form 
responsible for increasing HIV infectivity. PAP248-286 has an unusual amount of 
structural disorder when bound to the membrane as compared to other amyloid 
proteins, which may facilitate the binding of virus particles by maximizing the 
radius of capture for incoming virus particles. The disordered N-terminal end also 
has a high percentage of positively charged residues, which can interact with 




disorder and high positive charge at the N-terminus of PAP248-286 may be linked 
to the high affinity of the SEVI amyloid fiber for the HIV virus and the remarkable 
enhancement of HIV infectivity by the SEVI amyloid fiber if this disorder persists 
in the amyloid state as predicted. Although the peptide is mostly disordered, two 
ordered regions of the peptide are consistent with bioinformatic predictions of 
high amyloidogenic propensity. The regions of nascent structure in the peptide 
bear further investigation, especially by mutational analysis to identify residues 
that are particularly responsible for controlling SEVI formation. 
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CHAPTER 6. CONCLUSIONS AND FUTURE DIRECTIONS 
In type II diabetics, IAPP is the major component of the amyloid deposits 
found in the β-cells of pancreas. While initial studies on this peptide largely 
focused on identifying and characterizing the amyloidogenic segment of the 
peptide, emerging evidence supports the hypothesis that the intermediate helical 
species bound to the membrane are the highly toxic species. In particular, it has 
been shown that membrane aggregation (residues 1-19) and amyloid formation 
(residues 20-29) are two separate processes and the sequences responsible for 
these events are located in different regions within the same peptide. But the 
membrane bound α-helical intermediate structures of both the truncated or full 
length peptide were not available for IAPP. 
In order to provide insights into the misfolding pathway, as described in 
Chapter 2, we have solved the high-resolution structures and found the 
membrane orientations of human and rat IAPP1-19 using NMR experiments on 
dodecylphosphocholine micelles. The 1-19 fragment was chosen because 
previous studies suggested that this region is responsible for most of the 
membrane damage induced by hIAPP. While both peptides have similar α-helical 
folds, a drastic difference in their membrane topologies was observed. The rat 
IAPP1-19 is bound to the surface of the micelle whereas the human IAPP1-19 




hold insights into both the normal physiological action of IAPP and the damage to 
β-cell membranes caused by the pathological aggregation of IAPP. 
As discussed in Chapter 3, we extended our study to full-length rat IAPP, 
which forms an intermediate α-helical structure when bound to the membrane but 
does not form amyloid fibrils. In order to address this behavior of the peptide, we 
have solved the three-dimensional structure of full length rat IAPP in 
dodecylphosphocholine micelles. By comparing the rat IAPP structure with other 
toxic and nontoxic variants of IAPP, we have identified two structural features 
that correlate with the toxicity of the peptide. Rat IAPP is bound to the surface in 
a manner similar to that of the nontoxic rat IAPP1-19 and low-pH human IAPP1-19 
peptides and does not penetrate deeply into the micelle like the toxic neutral pH 
human IAPP1-19 peptide. The position of the N-terminal disulfide bridge has been 
identified as another factor that may modulate aggregation and toxicity. The 
nontoxic rat IAPP structure has a relatively rigid N-terminus that is bent toward 
the hydrophobic face of the amphipathic helix, whereas more toxic forms of IAPP 
have a more flexible N-terminus that is positioned away from the amphipathic 
helix. A comparison of the rat IAPP structure to other homologous peptides that 
share the same receptors, human IAPP, and fragments from the human IAPP 
sequence shows rat IAPP does not possess the β-turn seen in these peptides 
that is required to activate the receptor, but this region is flexible and may form a 
β-turn upon binding to the receptor. 
While the structure of human IAPP with a non-amidated C-terminus was 




amidation at the C-terminus and change in the His18 protonation state would 
have any influence on the structure of the human IAPP peptide at physiological 
pH. Therefore, as presented in Chapter 4, we have solved the structure of human 
IAPP with an amidated C-terminus in SDS micelles at pH 7.3. When compared 
with the non-amidated C-terminus human IAPP structure solved at pH 4.9, both 
structures have an overall kinked helix motif, with residues 7-17 and 21-28 in a 
helical conformation. However, the C-terminus of amidated human IAPP is 
structured, with a 310 dynamic helix from Gly33-Asn35, while the C-terminus is 
disordered in the structure of recombinant human IAPP solved at acidic pH. In 
addition, the angle between the N- and C-terminal helices is constrained to 85º 
instead of the free rotation present in the structure of recombinant human IAPP. 
These differences observed in our structure might play an important role in the 
aggregation process of human IAPP. 
Recently another amyloid peptide known as SEVI was discovered by 
Munch et al, in 2007 which drastically enhances the infection of HIV. But the 
structures of the SEVI are not known in any form making it difficult to predict the 
interactions of this peptide with the cell membrane that facilitate HIV viral 
attachment. Therefore, as elaborated in Chapter 5, we have solved the first high-
resolution structure of the SEVI precursor peptide PAP248-286 as a first step 
toward understanding the structural factors that drive PAP248-286 to form the 
amyloid fibers, which are identified as the form responsible for increasing HIV 
infectivity. PAP248-286 has an unusual amount of structural disorder when bound 




binding of virus particles by maximizing the radius of capture for incoming virus 
particles. The disordered N-terminal end also has a high percentage of positively 
charged residues, which can interact with multiple lipids on the virus surface. 
Furthermore, the combination of structural disorder and high positive charge at 
the N-terminus of PAP248-286 may be linked to the high affinity of the SEVI 
amyloid fiber for the HIV virus and the remarkable enhancement of HIV infectivity 
by the SEVI amyloid fiber, if this disorder persists in the amyloid state as 
predicted. Although the peptide is mostly disordered, two ordered regions of the 
peptide are consistent with bioinformatic predictions of high amyloidogenic 
propensity.  
All of the NMR structural studies, performed here involve utilization of the 
micelles. While micelles have a hydrophilic head group and a hydrophobic tail 
similar to that of the lipids and have the ability to trap these peptides in a non-
aggregated state, they differ from the real cell membrane by having a curved 
surface rather than a planar surface. Therefore, these structural studies can be 
further extended to bicelles or planar lipid bilayers that possess a planar 
curvature. However, the lipid-induced rapid aggregation of IAPP is a major 
challenge for high-resolution structural studies using NMR spectroscopy. Even 
optimization of conditions to prepare isotropic bicelles containing IAPP for 
solution NMR studies is challenging. 
It would be also interesting to see if the transition from α-helical 
intermediate to β-sheet could be studied at the atomic-level by monitoring the 




intermediate with bicelles consisting of a mixture of different lipids. In this context, 
it is worth exploring the structure of the peptide using aligned bicelles for solid-
state NMR measurements using sophisticated techniques like BB-PISEMA, 
HIMSELF/HERSELF, PELF, PELF-mixing, and DREPT [1-6]. These techniques 
have successfully been applied to solve the high-resolution images of 
membrane-associted cytochrome b5 embedded in large bicelles. 
Since the oligomers are known to be cytotoxic to the cell membrane, any 
further research progress in trapping these oligomers suitable for NMR structural 
studies would be the key in understanding the mechanism of cytotoxicity as well 
as to design the novel drugs for treatment of these amyloid diseases. Trapping 
the oligomers in lipid bilayers and applying solid-state NMR techniques for high-
resolution studies could be the best approach to overcome these challenges. 
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